{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 3938, "items": [{"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T00:46:49Z", "timestamp": 1574297209985}, "reference-count": 30, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 5, 1]], "date-time": "2009-05-01T00:00:00Z", "timestamp": 1241136000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The American Journal of Medicine"], "published-print": {"date-parts": [[2009, 5]]}, "DOI": "10.1016/j.amjmed.2009.03.002", "type": "journal-article", "created": {"date-parts": [[2009, 4, 24]], "date-time": "2009-04-24T08:23:54Z", "timestamp": 1240561434000}, "page": "S3-S9", "source": "Crossref", "is-referenced-by-count": 23, "title": ["Defining the Problem of Treating the Patient with Hypertension and Arthritis Pain"], "prefix": "10.1016", "volume": "122", "author": [{"given": "William B.", "family": "White", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["The American Journal of Medicine"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S000293430900206X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S000293430900206X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 20]], "date-time": "2018-12-20T08:57:48Z", "timestamp": 1545296268000}, "score": 48.249596, "issued": {"date-parts": [[2009, 5]]}, "references-count": 30, "journal-issue": {"published-print": {"date-parts": [[2009, 5]]}, "issue": "5"}, "alternative-id": ["S000293430900206X"], "URL": "http://dx.doi.org/10.1016/j.amjmed.2009.03.002", "ISSN": ["0002-9343"], "issn-type": [{"value": "0002-9343", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T02:37:22Z", "timestamp": 1574131042595}, "reference-count": 16, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "2", "content-domain": {"domain": ["ahajournals.org"], "crossmark-restriction": true}, "short-container-title": ["Hypertension"], "published-print": {"date-parts": [[2004, 8]]}, "DOI": "10.1161/01.hyp.0000136129.18326.26", "type": "journal-article", "created": {"date-parts": [[2004, 6, 29]], "date-time": "2004-06-29T00:14:41Z", "timestamp": 1088468081000}, "page": "123-124", "update-policy": "http://dx.doi.org/10.1161/crossmarkpolicy", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Hypertension Associated With Therapies to Treat Arthritis and Pain"], "prefix": "10.1161", "volume": "44", "author": [{"given": "William B.", "family": "White", "sequence": "first", "affiliation": [{"name": "From the Division of Hypertension and Clinical Pharmacology, Center for Cardiology and Cardiovascular Biology, University of Connecticut School of Medicine, Farmington."}]}], "member": "276", "reference": [{"key": "e_1_3_1_1_2", "DOI": "10.1001/jama.284.10.1247", "doi-asserted-by": "publisher"}, {"key": "e_1_3_1_2_2", "DOI": "10.1056/NEJM200011233432103", "doi-asserted-by": "publisher"}, {"key": "e_1_3_1_3_2", "DOI": "10.1073/pnas.96.1.272", "doi-asserted-by": "publisher"}, {"key": "e_1_3_1_4_2", "volume": "29", "first-page": "1501", "year": "2002", "journal-title": "J Rheumatol"}, {"key": "e_1_3_1_5_2", "DOI": "10.1016/S0895-7061(00)01204-8", "doi-asserted-by": "publisher"}, {"key": "e_1_3_1_6_2", "DOI": "10.1001/archinte.1993.00410040045007", "doi-asserted-by": "publisher"}, {"key": "e_1_3_1_7_2", "DOI": "10.7326/0003-4819-121-4-199408150-00011", "doi-asserted-by": "publisher"}, {"key": "e_1_3_1_8_2", "DOI": "10.1016/S0002-9149(02)02661-9", "doi-asserted-by": "publisher"}, {"key": "e_1_3_1_9_2", "DOI": "10.1161/01.hyp.0000014323.99765.16", "doi-asserted-by": "publisher"}, {"key": "e_1_3_1_10_2", "volume": "41", "first-page": "320A.", "year": "2003", "journal-title": "J Am Coll Cardiol"}, {"key": "e_1_3_1_11_2", "DOI": "10.1067/mcp.2002.126182", "doi-asserted-by": "publisher"}, {"key": "e_1_3_1_12_2", "DOI": "10.1161/01.hyp.0000136134.31846.83", "doi-asserted-by": "publisher"}, {"key": "e_1_3_1_13_2", "DOI": "10.1161/01.cir.0000127578.21885.3e", "doi-asserted-by": "publisher"}, {"key": "e_1_3_1_14_2", "DOI": "10.1161/hyp.35.5.1021", "doi-asserted-by": "publisher"}, {"key": "e_1_3_1_15_2", "DOI": "10.1001/jama.283.15.1967", "doi-asserted-by": "publisher"}, {"key": "e_1_3_1_16_2", "DOI": "10.1161/01.hyp.0000116221.27079.ea", "doi-asserted-by": "publisher"}], "container-title": ["Hypertension"], "language": "en", "deposited": {"date-parts": [[2018, 9, 28]], "date-time": "2018-09-28T12:52:03Z", "timestamp": 1538139123000}, "score": 30.693275, "issued": {"date-parts": [[2004, 8]]}, "references-count": 16, "journal-issue": {"published-print": {"date-parts": [[2004, 8]]}, "issue": "2"}, "alternative-id": ["10.1161/01.HYP.0000136129.18326.26"], "URL": "http://dx.doi.org/10.1161/01.hyp.0000136129.18326.26", "relation": {"cites": []}, "ISSN": ["0194-911X", "1524-4563"], "issn-type": [{"value": "0194-911X", "type": "print"}, {"value": "1524-4563", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T15:39:16Z", "timestamp": 1574523556546}, "publisher-location": "Milano", "reference-count": 70, "publisher": "Springer Milan", "isbn-type": [{"value": "9788847026001", "type": "print"}, {"value": "9788847026018", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012]]}, "DOI": "10.1007/978-88-470-2601-8_28", "type": "book-chapter", "created": {"date-parts": [[2012, 12, 20]], "date-time": "2012-12-20T13:10:48Z", "timestamp": 1356009048000}, "page": "373-387", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Treating Pain and Inflammation in Hypertension"], "prefix": "10.1007", "author": [{"given": "William B.", "family": "White", "sequence": "first", "affiliation": []}, {"given": "Ravi", "family": "Marfatia", "sequence": "additional", "affiliation": []}, {"given": "William L.", "family": "Baker", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2012, 12, 21]]}, "reference": [{"key": "28_CR1", "doi-asserted-by": "publisher", "first-page": "161", "DOI": "10.1001/archinte.165.2.161", "volume": "165", "author": "JR Sowers", "year": "2005", "unstructured": "Sowers JR, White WB, Pitt B et al (2005) The effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis and type 2 diabetes. Arch Intern Med 165:161\u2013168", "journal-title": "Arch Intern Med"}, {"key": "28_CR2", "unstructured": "Fries S, Grosser T (2005). The cardiovascular pharmacology of COX-2 inhibition. Hematology Am Soc Hematol Educ Program 445\u2013451", "DOI": "10.1182/asheducation-2005.1.445", "doi-asserted-by": "crossref"}, {"key": "28_CR3", "doi-asserted-by": "publisher", "first-page": "698", "DOI": "10.1038/9550", "volume": "5", "author": "DW Gilroy", "year": "1999", "unstructured": "Gilroy DW, Colville-Nash PR et al (1999) Inducible cyclooygenase may have anti-inflammatory properties. Nat Med 5:698\u2013701", "journal-title": "Nat Med"}, {"key": "28_CR4", "doi-asserted-by": "publisher", "first-page": "3147", "DOI": "10.2174/0929867043363668", "volume": "11", "author": "W Kiefer", "year": "2004", "unstructured": "Kiefer W, Dannhardt G (2004) Novel insights and therapeutic applications in the field of inhibitors of COX-2. Curr Med Chem 11:3147\u20133161", "journal-title": "Curr Med Chem"}, {"key": "28_CR5", "doi-asserted-by": "publisher", "first-page": "431", "DOI": "10.1080/10408360091174286", "volume": "37", "author": "E Fosslien", "year": "2000", "unstructured": "Fosslien E (2000) Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia. Crit Rev Clin Lab Sci 37:431\u2013502", "journal-title": "Crit Rev Clin Lab Sci"}, {"key": "28_CR6", "doi-asserted-by": "publisher", "first-page": "396", "DOI": "10.1161/01.HYP.0000140925.73081.4c", "volume": "44", "author": "CM Hao", "year": "2004", "unstructured": "Hao CM, Breyer MD (2004) Hypertension and cyclooxygenase inhibitors. Target: the renal medulla. Hypertension 44:396\u2013397", "journal-title": "Hypertension"}, {"key": "28_CR7", "doi-asserted-by": "publisher", "first-page": "543", "DOI": "10.1111/j.1365-201X.2004.01329.x", "volume": "181", "author": "RC Harris", "year": "2004", "unstructured": "Harris RC, Zhang MZ, Cheng HF (2004) Cyclooxygenase-2 and the renal angiotensin system. Acta Physiol Scand 181:543\u2013547", "journal-title": "Acta Physiol Scand"}, {"key": "28_CR8", "doi-asserted-by": "publisher", "first-page": "1161", "DOI": "10.1016/S0895-7061(00)01204-8", "volume": "13", "author": "TO Morgan", "year": "2000", "unstructured": "Morgan TO, Anderson A, Bertram D (2000) Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. Am J Hypertens 13:1161\u20131167", "journal-title": "Am J Hypertens"}, {"key": "28_CR9", "doi-asserted-by": "publisher", "first-page": "50", "DOI": "10.1067/mcp.2002.126182", "volume": "72", "author": "JI Schwartz", "year": "2002", "unstructured": "Schwartz JI, Vandormael K, Malice MP et al (2002) Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin Pharmacol Ther 72:50\u201361", "journal-title": "Clin Pharmacol Ther"}, {"key": "28_CR10", "first-page": "1501", "volume": "29", "author": "LS Simon", "year": "2002", "unstructured": "Simon LS, Smolen JS, Abramson SB et al (2002) Controversies in COX-2 selective inhibition. J Rheumatol 29:1501\u20131510", "journal-title": "J Rheumatol"}, {"key": "28_CR11", "doi-asserted-by": "publisher", "first-page": "65S", "DOI": "10.1016/S0002-9343(99)00369-1", "volume": "107", "author": "DC Brater", "year": "1999", "unstructured": "Brater DC (1999) Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2\u2014selective inhibition. Am J Med 107:65S\u201370S", "journal-title": "Am J Med"}, {"key": "28_CR12", "doi-asserted-by": "publisher", "first-page": "1465", "DOI": "10.1001/archinte.160.10.1465", "volume": "160", "author": "A Whelton", "year": "2000", "unstructured": "Whelton A, Schulman G, Wallemark C et al (2000) Effects of celecoxib and naproxen on renal function in the elderly. Arch Intern Med 160:1465\u20131470", "journal-title": "Arch Intern Med"}, {"key": "28_CR13", "doi-asserted-by": "publisher", "first-page": "959", "DOI": "10.1016/S0002-9149(02)02661-9", "volume": "90", "author": "A Whelton", "year": "2002", "unstructured": "Whelton A, White WB, Bello AE et al (2002) Effects of celecoxib and rofecoxib on blood pressure and edema in patients \u226565\u00a0years of age with systemic hypertension and osteoarthritis. Am J Cardiol 90:959\u2013963", "journal-title": "Am J Cardiol"}, {"issue": "5B", "key": "28_CR14", "doi-asserted-by": "crossref", "first-page": "13S", "DOI": "10.1016/S0002-9343(99)00113-8", "volume": "106", "author": "A Whelton", "year": "1999", "unstructured": "Whelton A (1999). Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 106(5B):13S\u201324S", "journal-title": "Am J Med"}, {"key": "28_CR15", "doi-asserted-by": "crossref", "first-page": "61", "DOI": "10.1172/JCI0214752", "volume": "110", "author": "Z Qi", "year": "2002", "unstructured": "Qi Z, Hao CM, Langenbach RI et al (2002) Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest 110:61\u201369", "journal-title": "J Clin Invest"}, {"key": "28_CR16", "doi-asserted-by": "publisher", "first-page": "2308", "DOI": "10.1161/01.CIR.0000101683.30157.0B", "volume": "108", "author": "M Hermann", "year": "2003", "unstructured": "Hermann M, Camici G, Fratton A et al (2003) Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension. Circulation 108:2308\u20132311", "journal-title": "Circulation"}, {"key": "28_CR17", "doi-asserted-by": "publisher", "first-page": "193", "DOI": "10.1161/01.HYP.0000153053.82032.bf", "volume": "45", "author": "H Hermann", "year": "2005", "unstructured": "Hermann H, Shaw S, Kiss E et al (2005) Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension. Hypertension 45:193\u2013197", "journal-title": "Hypertension"}, {"key": "28_CR18", "first-page": "P", "volume": "11", "author": "LK Winner", "year": "2005", "unstructured": "Winner LK, Elliot DJ, Miners JO et al. (2005) In vitro glucuronidation of aldosterone by human liver and kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UCT) 287: inhibition by non-steroidal anti-inflammatory drugs (NSAIDs). Proc Aust Soc Clin Exp Pharmacol Toxicol 11:P-2-02", "journal-title": "Proc Aust Soc Clin Exp Pharmacol Toxicol"}, {"key": "28_CR19", "doi-asserted-by": "publisher", "first-page": "738", "DOI": "10.1111/j.1365-2125.2006.02678.x", "volume": "61", "author": "KM Knights", "year": "2006", "unstructured": "Knights KM, Mangoni AA, Minors JO (2006) Non-selective nonsteroidal anti-inflammatory drugs and cardiovascular events: is aldosterone the silent partner in crime? Br J Clin Pharmacol 61:738\u2013740", "journal-title": "Br J Clin Pharmacol"}, {"key": "28_CR20", "doi-asserted-by": "publisher", "first-page": "477", "DOI": "10.1001/archinte.1993.00410040045007", "volume": "153", "author": "JE Pope", "year": "1993", "unstructured": "Pope JE, Anderson JJ, Felson DT (1993) A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 153:477\u2013484", "journal-title": "Arch Intern Med"}, {"key": "28_CR21", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.7326/0003-4819-121-4-199408150-00011", "volume": "121", "author": "AG Johnson", "year": "1994", "unstructured": "Johnson AG, Nguyen TV, Day RO (1994) Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 121:289\u2013300", "journal-title": "Ann Intern Med"}, {"key": "28_CR22", "doi-asserted-by": "publisher", "first-page": "604", "DOI": "10.1161/01.HYP.0000035856.77718.DA", "volume": "40", "author": "J Dedier", "year": "2002", "unstructured": "Dedier J, Stampfer MJ, Hankinson SE et al (2002) Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension 40:604\u2013608", "journal-title": "Hypertension"}, {"key": "28_CR23", "doi-asserted-by": "publisher", "first-page": "1903", "DOI": "10.1001/archinte.165.16.1903", "volume": "165", "author": "T Kurth", "year": "2005", "unstructured": "Kurth T, Hennekens CH, Sturmer T et al (2005) Analgesic use and risk of subsequent hypertension in apparently healthy men. Arch Intern Med 165:1903\u20131909", "journal-title": "Arch Intern Med"}, {"key": "28_CR24", "first-page": "600", "volume": "36", "author": "JP Forman", "year": "2005", "unstructured": "Forman JP, Stampfer MJ, Curhan GC (2005) Non-narcotic analgesic dose and risk of incident hypertension in US women. Hypertension 36:600\u2013607", "journal-title": "Hypertension"}, {"key": "28_CR25", "first-page": "1143", "volume": "31", "author": "F Wolfe", "year": "2004", "unstructured": "Wolfe F, Zhao S, Pettitt D (2004) Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal anti-inflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care. J Rheumatol 31:1143\u20131151", "journal-title": "J Rheumatol"}, {"key": "28_CR26", "doi-asserted-by": "publisher", "first-page": "445", "DOI": "10.1038/sj.jhh.1001839", "volume": "19", "author": "R Sheridan", "year": "2005", "unstructured": "Sheridan R, Montgomery AA, Fahey T (2005) NSAID use and BP in treated hypertensives: a retrospective controlled observational study. J Hum Hypertens 19:445\u2013450", "journal-title": "J Hum Hypertens"}, {"key": "28_CR27", "doi-asserted-by": "publisher", "first-page": "1007", "DOI": "10.1097/00004872-200205000-00037", "volume": "20", "author": "R Fogari", "year": "2002", "unstructured": "Fogari R, Zoppi A, Carretta R et al (2002) Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicenter study. J Hypertens 20:1007\u20131014", "journal-title": "J Hypertens"}, {"key": "28_CR28", "doi-asserted-by": "publisher", "first-page": "363", "DOI": "10.1111/j.1365-2125.1991.tb05546.x", "volume": "31", "author": "MA Abate", "year": "1991", "unstructured": "Abate MA, Neely JL, Layne RD et al (1991) Interaction of indomethacin and sulindac with labetalol. Br J Clin Pharmacol 31:363\u2013366", "journal-title": "Br J Clin Pharmacol"}, {"key": "28_CR29", "doi-asserted-by": "publisher", "first-page": "135", "DOI": "10.1016/S0895-7061(02)03203-X", "volume": "16", "author": "R Palmer", "year": "2003", "unstructured": "Palmer R, Weiss R, Zusman RM et al (2003) Effects of nabumetone, celecoxib, and ibuprofen on blood pressure control in hypertensive patients on angiotensin converting enzyme inhibitors. Am J Hypertens 16:135\u2013139", "journal-title": "Am J Hypertens"}, {"key": "28_CR30", "doi-asserted-by": "publisher", "first-page": "1049", "DOI": "10.1001/archinte.1995.00430100075009", "volume": "155", "author": "MC Houston", "year": "1995", "unstructured": "Houston MC, Weir M, Gray J et al (1995) The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patents with hypertension controlled by verapamil. Arch Intern Med 155:1049\u20131054", "journal-title": "Arch Intern Med"}, {"key": "28_CR31", "doi-asserted-by": "publisher", "first-page": "146", "DOI": "10.1016/0895-7061(94)00164-7", "volume": "8", "author": "DK Klassen", "year": "1995", "unstructured": "Klassen DK, Jane LH, Young DY et al (1995) Assessment of blood pressure during naproxen therapy in hypertensive patients treated with nicardipine. Am J Hypertens 8:146\u2013153", "journal-title": "Am J Hypertens"}, {"key": "28_CR32", "doi-asserted-by": "crossref", "first-page": "92", "DOI": "10.1161/01.HYP.0000149684.01903.b8", "volume": "45", "author": "SA Grover", "year": "2005", "unstructured": "Grover SA, Coupal L, Zowall H (2005) Treating osteoarthritis with cyclooxygenase-2-specific inhibitors. What are the benefits of avoiding blood pressure destabilization? Hypertension 45:92\u201397", "journal-title": "Hypertension"}, {"key": "28_CR33", "doi-asserted-by": "publisher", "first-page": "76", "DOI": "10.1016/S0009-9236(99)70056-1", "volume": "66", "author": "J Rossat", "year": "1999", "unstructured": "Rossat J, Maillard M, Nussberger J et al (1999) Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin Pharmacol Ther 66:76\u201384", "journal-title": "Clin Pharmacol Ther"}, {"key": "28_CR34", "first-page": "735", "volume": "289", "author": "F Catella-Lawson", "year": "1999", "unstructured": "Catella-Lawson F, McAdam B, Morrison BW et al (1999) Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther 289:735\u2013741", "journal-title": "J Pharmacol Exp Ther"}, {"key": "28_CR35", "doi-asserted-by": "publisher", "first-page": "140", "DOI": "10.1161/01.HYP.0000136134.31846.83", "volume": "44", "author": "DH Solomon", "year": "2004", "unstructured": "Solomon DH, Schneeweiss S, Levin R, Avorn J (2004) Relationship between COX-2 specific inhibitors and hypertension. Hypertension 44:140\u2013145", "journal-title": "Hypertension"}, {"key": "28_CR36", "doi-asserted-by": "publisher", "first-page": "929", "DOI": "10.1161/01.HYP.0000014323.99765.16", "volume": "39", "author": "WB White", "year": "2002", "unstructured": "White WB, Kent J, Taylor A et al (2002) Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors. Hypertension 39:929\u2013934", "journal-title": "Hypertension"}, {"key": "28_CR37", "doi-asserted-by": "publisher", "first-page": "2332", "DOI": "10.1097/HJH.0b013e3283310dc9", "volume": "27", "author": "CC Chan", "year": "2009", "unstructured": "Chan CC, Reid CM, Aw TJ et al (2009) Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis. J Hypertens 27:2332\u20132341", "journal-title": "J Hypertens"}, {"key": "28_CR38", "doi-asserted-by": "publisher", "first-page": "1751", "DOI": "10.1016/S0140-6736(04)16299-5", "volume": "363", "author": "M Mamdani", "year": "2004", "unstructured": "Mamdani M, Juurlink DN, Lee DS et al (2004) Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive failure outcomes in elderly patients: a population-based cohort study. Lancet 363:1751\u20131756", "journal-title": "Lancet"}, {"key": "28_CR39", "doi-asserted-by": "publisher", "first-page": "1634", "DOI": "10.1161/CIRCULATIONAHA.106.181424", "volume": "115", "author": "EM Antman", "year": "2007", "unstructured": "Antman EM, Bennett JS, Daugherty A et al (2007) Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American heart association. Circulation 115:1634\u20131642", "journal-title": "Circulation"}, {"key": "28_CR40", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1016/j.clpt.2005.09.009", "volume": "79", "author": "DM Aronoff", "year": "2006", "unstructured": "Aronoff DM, Oates JA, Boutaud O (2006) New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Ther 79:9\u201319", "journal-title": "Clin Pharmacol Ther"}, {"key": "28_CR41", "doi-asserted-by": "publisher", "first-page": "280", "DOI": "10.1016/j.ejphar.2005.12.015", "volume": "531", "author": "A Ottani", "year": "2006", "unstructured": "Ottani A, Leone S, Sandrini M et al (2006) The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors. Eur J Pharmacol 531:280\u2013281", "journal-title": "Eur J Pharmacol"}, {"key": "28_CR42", "doi-asserted-by": "publisher", "first-page": "33", "DOI": "10.1016/j.ejphar.2004.06.011", "volume": "496", "author": "BG Kelley", "year": "2004", "unstructured": "Kelley BG, Thayer SA (2004) Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors. Eur J Pharmacol 496:33\u201339", "journal-title": "Eur J Pharmacol"}, {"key": "28_CR43", "first-page": "717", "volume": "152", "author": "AJ Wheat", "year": "2007", "unstructured": "Wheat AJ, Bennett T, Randall MD, Gardiner SM (2007) Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats. Br J Pharmacol 152:717\u2013724", "journal-title": "Br J Pharmacol"}, {"key": "28_CR44", "first-page": "1", "volume": "103", "author": "R Bjorkman", "year": "1995", "unstructured": "Bjorkman R (1995) Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol: experimental studies in the rat. Acta Anaesthesiol Scand Suppl 103:1\u201344", "journal-title": "Acta Anaesthesiol Scand Suppl"}, {"key": "28_CR45", "doi-asserted-by": "publisher", "first-page": "349", "DOI": "10.2353/ajpath.2006.050090", "volume": "168", "author": "RS Deep", "year": "2006", "unstructured": "Deep RS, Shen H, Gamss C et al (2006) Inducible nitric oxide synthase mediates prostaglandin H2 synthase nitration and suppresses eicosanoid production. Am J Pathol 168:349\u2013362", "journal-title": "Am J Pathol"}, {"key": "28_CR46", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.1096/fj.07-8506com", "volume": "22", "author": "B Hinz", "year": "2008", "unstructured": "Hinz B, Cheremina O, Brune K (2008) Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J 22:383\u2013390", "journal-title": "FASEB J"}, {"key": "28_CR47", "doi-asserted-by": "publisher", "first-page": "20", "DOI": "10.1136/ard.2011.200087", "volume": "71", "author": "B Hinz", "year": "2012", "unstructured": "Hinz B, Brune K (2012) Paracetamol and cyclooxygenase inhibition: is there a cause for concern? Ann Rheum Dis 71:20\u201325", "journal-title": "Ann Rheum Dis"}, {"key": "28_CR48", "doi-asserted-by": "publisher", "first-page": "394", "DOI": "10.1001/archinte.167.4.394", "volume": "167", "author": "JP Forman", "year": "2007", "unstructured": "Forman JP, Rimm EB, Curhan GC (2007) Frequency of analgesic use and risk of hypertension among men. Arch Intern Med 167:394\u2013399", "journal-title": "Arch Intern Med"}, {"key": "28_CR49", "doi-asserted-by": "publisher", "first-page": "1190", "DOI": "10.1136/bmj.39526.654016.AD", "volume": "336", "author": "B Montgomery", "year": "2008", "unstructured": "Montgomery B (2008) Does paracetamol cause hypertension? BMJ 336:1190\u20131191", "journal-title": "BMJ"}, {"key": "28_CR50", "doi-asserted-by": "publisher", "first-page": "1789", "DOI": "10.1161/CIRCULATIONAHA.110.956490", "volume": "122", "author": "I Sudano", "year": "2010", "unstructured": "Sudano I, Flammer AJ, P\u00e9riat D et al (2010) Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation 122:1789\u20131796", "journal-title": "Circulation"}, {"key": "28_CR51", "doi-asserted-by": "publisher", "first-page": "574", "DOI": "10.1161/01.HYP.0000115921.55353.e0", "volume": "43", "author": "M Izhar", "year": "2004", "unstructured": "Izhar M, Alausa T, Folker A et al (2004) Effects of COX-inhibition on blood pressure and kidney function in ACE inhibitor-treated blacks and Hispanics. Hypertension 43:574\u2013577", "journal-title": "Hypertension"}, {"key": "28_CR52", "doi-asserted-by": "publisher", "first-page": "1695", "DOI": "10.1097/HJH.0b013e328302c9fe", "volume": "26", "author": "T MacDonald", "year": "2008", "unstructured": "MacDonald T, Reginster J-Y, Littlejohn TW et al (2008) Effect on blood pressure of lumiracoxib versus ibuprofen in patients with osteoarthritis and controlled hypertension: a randomized trial. J Hypertens 26:1695\u20131704", "journal-title": "J Hypertens"}, {"key": "28_CR53", "doi-asserted-by": "publisher", "first-page": "925", "DOI": "10.1097/00004872-199508000-00014", "volume": "13", "author": "J Polonia", "year": "1995", "unstructured": "Polonia J, Boaventura I, Gama G et al (1995) Influence of non-steroidal anti-inflammatory drugs on renal function and 24\u00a0h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients. J Hypertens 13:925\u2013931", "journal-title": "J Hypertens"}, {"key": "28_CR54", "doi-asserted-by": "publisher", "first-page": "1521", "DOI": "10.1177/0091270007307878", "volume": "47", "author": "J Schwartz", "year": "2007", "unstructured": "Schwartz J, Thach C, Lasseter KC et al (2007) Effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs on urinary sodium excretion, blood pressure, and other renal function indicators in elderly subjects consuming a controlled sodium diet. J Clin Pharmacol 47:1521\u20131531", "journal-title": "J Clin Pharmacol"}, {"key": "28_CR55", "doi-asserted-by": "publisher", "first-page": "1779", "DOI": "10.1161/CIRCULATIONAHA.110.984054", "volume": "122", "author": "WB White", "year": "2010", "unstructured": "White WB, Campbell P (2010) Blood pressure destabilization on nonsteroidal antiinflammatory agents acetaminophen exposed? Circulation 122:1779\u20131781", "journal-title": "Circulation"}, {"key": "28_CR56", "doi-asserted-by": "publisher", "first-page": "234", "DOI": "10.1097/00000441-199605000-00007", "volume": "311", "author": "T Pensabeni-Jasper", "year": "1996", "unstructured": "Pensabeni-Jasper T, Panush RS (1996) Review: corticosteroid usage: observations at a community hospital. Am J Med Sci 311:234", "journal-title": "Am J Med Sci"}, {"key": "28_CR57", "doi-asserted-by": "publisher", "first-page": "267", "DOI": "10.1111/j.1440-1797.2003.00215.x", "volume": "8", "author": "GJ Mangos", "year": "2003", "unstructured": "Mangos GJ, Whitworth JA, Williamson PM, Kelly JJ (2003) Glucocorticoids and the kidney. Nephrology 8:267\u2013273", "journal-title": "Nephrology"}, {"key": "28_CR58", "doi-asserted-by": "publisher", "first-page": "142", "DOI": "10.1111/j.1365-2133.2007.07950.x", "volume": "157", "author": "L Fardet", "year": "2007", "unstructured": "Fardet L, Flahault A, Kettaneh A et al (2007) Corticosteroid-induced clinical adverse events: frequency, risk factors and patient\u2019s opinion. Br J Dermatol 157:142\u2013148", "journal-title": "Br J Dermatol"}, {"key": "28_CR59", "doi-asserted-by": "publisher", "first-page": "829", "DOI": "10.1136/hrt.2003.031492", "volume": "90", "author": "MK Ng", "year": "2004", "unstructured": "Ng MK, Celermajer DS (2004) Glucocorticoid treatment and cardiovascular disease. Heart 90:829\u2013830", "journal-title": "Heart"}, {"key": "28_CR60", "doi-asserted-by": "publisher", "first-page": "859", "DOI": "10.1136/hrt.2003.020180", "volume": "90", "author": "PC Souverein", "year": "2004", "unstructured": "Souverein PC, Berard A, Van Staa TP et al (2004) Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case\u2013control study. Heart 90:859\u2013865", "journal-title": "Heart"}, {"issue": "Suppl 68", "key": "28_CR61", "first-page": "S85", "volume": "29", "author": "NA Smits", "year": "2011", "unstructured": "Smits NA, Duru N, Bijlsma JW, Jacobs JW (2011) Adverse events of intravenous glucocorticoid pulse therapy in inflammatory diseases: a meta-analysis. Clin Exp Rheumatol 29(Suppl 68):S85\u2013S92", "journal-title": "Clin Exp Rheumatol"}, {"key": "28_CR62", "doi-asserted-by": "publisher", "first-page": "552", "DOI": "10.3899/jrheum.110851", "volume": "39", "author": "M Mazzantini", "year": "2012", "unstructured": "Mazzantini M, Torre C, Miccoli M et al (2012) Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study. J Rheumatol 39:552\u2013557", "journal-title": "J Rheumatol"}, {"key": "28_CR63", "doi-asserted-by": "publisher", "first-page": "268", "DOI": "10.1126/science.3037703", "volume": "237", "author": "JL Arriza", "year": "1987", "unstructured": "Arriza JL, Weinberger C, Cerelli G et al (1987) Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268\u2013275", "journal-title": "Science"}, {"key": "28_CR64", "doi-asserted-by": "publisher", "first-page": "583", "DOI": "10.1126/science.2845584", "volume": "242", "author": "JW Funder", "year": "1988", "unstructured": "Funder JW, Pearc PT, Smith R et al (1988) Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242:583\u2013585", "journal-title": "Science"}, {"key": "28_CR65", "doi-asserted-by": "publisher", "first-page": "113", "DOI": "10.1016/S0083-6729(03)01004-5", "volume": "66", "author": "P Ferrari", "year": "2003", "unstructured": "Ferrari P, Bonny O (2003) Forms of mineralocorticoid hypertension. Vitam Horm 66:113\u2013156", "journal-title": "Vitam Horm"}, {"key": "28_CR66", "doi-asserted-by": "publisher", "first-page": "1060", "DOI": "10.1210/jcem-72-5-1060", "volume": "72", "author": "M Montrella-Waybill", "year": "1991", "unstructured": "Montrella-Waybill M, Clore JN, Schoolwerth AC, Watlington CO (1991) Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor. J Clin Endocrinol Metab 72:1060\u20131066", "journal-title": "J Clin Endocrinol Metab"}, {"key": "28_CR67", "doi-asserted-by": "publisher", "first-page": "S37", "DOI": "10.1097/00004872-199610003-00007", "volume": "14", "author": "PM Williamson", "year": "1996", "unstructured": "Williamson PM, Kelly JJ, Whitworth JA (1996) Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans. J Hypertens 14:S37\u2013S41", "journal-title": "J Hypertens"}, {"key": "28_CR68", "doi-asserted-by": "publisher", "first-page": "2240", "DOI": "10.1016/0006-2952(68)90203-7", "volume": "17", "author": "DD Fanestil", "year": "1968", "unstructured": "Fanestil DD (1968) Mode of spironolactone action: competitive inhibition of aldosterone binding to kidney mineralocorticoid receptors. Biochem Pharmacol 17:2240\u20132242", "journal-title": "Biochem Pharmacol"}, {"key": "28_CR69", "doi-asserted-by": "publisher", "first-page": "840", "DOI": "10.1016/j.amjcard.2009.05.014", "volume": "104", "author": "WB White", "year": "2009", "unstructured": "White WB, Schnitzer TJ, Fleming R, Duquesroix B, Beekman M (2009) Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis. Am J Cardiol 104:840\u2013845", "journal-title": "Am J Cardiol"}, {"key": "28_CR70", "doi-asserted-by": "publisher", "first-page": "285", "DOI": "10.1016/j.phrs.2009.01.011", "volume": "59", "author": "C Patrono", "year": "2009", "unstructured": "Patrono C, Rocca B (2009) Nonsteroidal antiinflammatory drugs: past, present, and future. Pharmacol Res 59:285\u2013289", "journal-title": "Pharmacol Res"}], "container-title": ["Special Issues in Hypertension"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-88-470-2601-8_28", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 5]], "date-time": "2019-11-05T09:24:59Z", "timestamp": 1572945899000}, "score": 28.343733, "issued": {"date-parts": [[2012]]}, "ISBN": ["9788847026001", "9788847026018"], "references-count": 70, "URL": "http://dx.doi.org/10.1007/978-88-470-2601-8_28", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T03:15:29Z", "timestamp": 1574565329673}, "reference-count": 27, "publisher": "Wiley", "issue": "6", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 5, 1]], "date-time": "2015-05-01T00:00:00Z", "timestamp": 1430438400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "start": {"date-parts": [[2015, 5, 25]], "date-time": "2015-05-25T00:00:00Z", "timestamp": 1432512000000}, "delay-in-days": 24, "content-version": "vor"}], "funder": [{"name": "New Zealand Manipulative Physiotherapists Association", "award": []}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arthritis Care & Research"], "published-print": {"date-parts": [[2015, 5]]}, "DOI": "10.1002/acr.22530", "type": "journal-article", "created": {"date-parts": [[2014, 12, 3]], "date-time": "2014-12-03T01:41:52Z", "timestamp": 1417570912000}, "page": "873-879", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Do Patients Undergoing Physical Testing Report Pain Intensity Reliably?"], "prefix": "10.1002", "volume": "67", "author": [{"given": "Steven G.", "family": "White", "sequence": "first", "affiliation": [{"name": "AUT University; Auckland New Zealand"}]}, {"given": "Peter", "family": "McNair", "sequence": "additional", "affiliation": [{"name": "AUT University; Auckland New Zealand"}]}, {"given": "Mark", "family": "Laslett", "sequence": "additional", "affiliation": [{"name": "AUT University; Auckland New Zealand"}]}, {"given": "Wayne", "family": "Hing", "sequence": "additional", "affiliation": [{"name": "Bond University; Queensland Australia"}]}], "member": "311", "published-online": {"date-parts": [[2015, 5, 25]]}, "reference": [{"key": "10.1002/acr.22530-BIB0001|acr22530-cit-0001", "doi-asserted-by": "crossref", "first-page": "98", "DOI": "10.1016/j.math.2006.07.012", "article-title": "Mulligan's mobilization-with-movement, positional faults and pain relief: current concepts from a critical review of literature", "volume": "12", "author": "Vicenzino", "year": "2007", "journal-title": "Man Ther"}, {"key": "10.1002/acr.22530-BIB0002|acr22530-cit-0002", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1136/bjsm.2008.052183", "article-title": "Rotator cuff tendinopathy/subacromial impingement syndrome: is it time for a new method of assessment?", "volume": "43", "author": "Lewis", "year": "2009", "journal-title": "Br J Sports Med"}, {"key": "10.1002/acr.22530-BIB0003|acr22530-cit-0003", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1016/S0004-9514(14)60244-0", "article-title": "Do within-session changes in pain intensity and range of motion predict between-session changes in patients with low back pain?", "volume": "50", "author": "Hahne", "year": "2004", "journal-title": "Aust J Physiother"}, {"key": "10.1002/acr.22530-BIB0004|acr22530-cit-0004", "first-page": "119", "article-title": "Statistical methodology for reliability studies", "volume": "14", "author": "Haas", "year": "1991", "journal-title": "J Manipulative Physiol Ther"}, {"key": "10.1002/acr.22530-BIB0005|acr22530-cit-0005", "doi-asserted-by": "crossref", "first-page": "1546", "DOI": "10.1093/ptj/81.9.1546", "article-title": "Examining diagnostic tests: an evidence-based perspective", "volume": "81", "author": "Fritz", "year": "2001", "journal-title": "Phys Ther"}, {"key": "10.1002/acr.22530-BIB0006|acr22530-cit-0006", "doi-asserted-by": "crossref", "first-page": "157", "DOI": "10.1016/S0304-3959(99)00101-3", "article-title": "Comparative reliability and validity of chronic pain intensity measures", "volume": "83", "author": "Jensen", "year": "1999", "journal-title": "Pain"}, {"key": "10.1002/acr.22530-BIB0007|acr22530-cit-0007", "doi-asserted-by": "crossref", "first-page": "1284", "DOI": "10.1111/j.1526-4637.2012.01470.x", "article-title": "Reliability and validity of individual and composite recall pain measures in patients with cancer", "volume": "13", "author": "Jensen", "year": "2012", "journal-title": "Pain Med"}, {"key": "10.1002/acr.22530-BIB0008|acr22530-cit-0008", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.2519/jospt.2004.34.4.187", "article-title": "The evaluation of change in pain intensity: a comparison of the P4 and single-item numeric pain rating scales", "volume": "34", "author": "Spadoni", "year": "2004", "journal-title": "J Orthop Sports Phys Ther"}, {"key": "10.1002/acr.22530-BIB0009|acr22530-cit-0009", "first-page": "1022", "article-title": "Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis", "volume": "17", "author": "Ferraz", "year": "1990", "journal-title": "J Rheumatol"}, {"key": "10.1002/acr.22530-BIB0010|acr22530-cit-0010", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.2519/jospt.2008.2677", "article-title": "The interrater reliability of 4 clinical tests used to assess individuals with musculoskeletal hip pain", "volume": "38", "author": "Martin", "year": "2008", "journal-title": "J Orthop Sports Phys Ther"}, {"key": "10.1002/acr.22530-BIB0011|acr22530-cit-0011", "first-page": "1690", "article-title": "Reliability of hip examination tests for femoroacetabular impingement", "volume": "65", "author": "Ratzlaff", "year": "2013", "journal-title": "Arthritis Care Res (Hoboken)"}, {"key": "10.1002/acr.22530-BIB0012|acr22530-cit-0012", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1016/j.jmpt.2009.04.010", "article-title": "A review of intraexaminer and interexaminer reliability of static spinal palpation: a literature synthesis", "volume": "32", "author": "Haneline", "year": "2009", "journal-title": "J Manipulative Physiol Ther"}, {"key": "10.1002/acr.22530-BIB0013|acr22530-cit-0013", "doi-asserted-by": "crossref", "first-page": "1898", "DOI": "10.1016/j.apmr.2009.05.015", "article-title": "Reliability and diagnostic accuracy of 5 physical examination tests and combination of tests for subacromial impingement", "volume": "90", "author": "Michener", "year": "2009", "journal-title": "Arch Phys Med Rehabil"}, {"key": "10.1002/acr.22530-BIB0014|acr22530-cit-0014", "doi-asserted-by": "crossref", "first-page": "52", "DOI": "10.1097/00007632-200301010-00014", "article-title": "Reliability and diagnostic accuracy of the clinical examination and patient self-report measures for cervical radiculopathy", "volume": "28", "author": "Wainner", "year": "2003", "journal-title": "Spine (Phila Pa 1976)"}, {"key": "10.1002/acr.22530-BIB0015|acr22530-cit-0015", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1016/j.math.2010.07.009", "article-title": "Interexaminer reliability of orthopaedic special tests used in the assessment of shoulder pain", "volume": "16", "author": "Cadogan", "year": "2011", "journal-title": "Man Ther"}, {"key": "10.1002/acr.22530-BIB0016|acr22530-cit-0016", "doi-asserted-by": "crossref", "first-page": "1243", "DOI": "10.1097/00007632-199405310-00009", "article-title": "The reliability of selected pain provocation tests for sacroiliac joint pathology", "volume": "19", "author": "Laslett", "year": "1994", "journal-title": "Spine (Phila Pa 1976)"}, {"key": "10.1002/acr.22530-BIB0017|acr22530-cit-0017", "doi-asserted-by": "crossref", "first-page": "676", "DOI": "10.2519/jospt.2004.34.11.676", "article-title": "Clinical hip tests and a functional squat test in patients with knee osteoarthritis: reliability, prevalence of positive test findings, and short-term response to hip mobilization", "volume": "34", "author": "Cliborne", "year": "2004", "journal-title": "J Orthop Sports Phys Ther"}, {"key": "10.1002/acr.22530-BIB0018|acr22530-cit-0018", "first-page": "257", "article-title": "The kappa statistic in reliability studies: use, interpretation, and sample size requirements", "volume": "85", "author": "Sim", "year": "2005", "journal-title": "Phys Ther"}, {"key": "10.1002/acr.22530-BIB0019|acr22530-cit-0019", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1081/BIP-120028508", "article-title": "Minimal important difference thresholds and the standard error of measurement: is there a connection?", "volume": "14", "author": "Wyrwich", "year": "2004", "journal-title": "J Biopharm Stat"}, {"key": "10.1002/acr.22530-BIB0020|acr22530-cit-0020", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.2307/2532051", "article-title": "A concordance correlation coefficient to evaluate reproducibility", "volume": "45", "author": "Lin", "year": "1989", "journal-title": "Biometrics"}, {"key": "10.1002/acr.22530-BIB0021|acr22530-cit-0021", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.2307/2529310", "article-title": "The measurement of observer agreement for categorical data", "volume": "33", "author": "Landis", "year": "1977", "journal-title": "Biometrics"}, {"key": "10.1002/acr.22530-BIB0022|acr22530-cit-0022", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1111/j.1547-5069.2007.00161.x", "article-title": "A psychometric toolbox for testing validity and reliability", "volume": "39", "author": "DeVon", "year": "2007", "journal-title": "J Nurs Scholarsh"}, {"key": "10.1002/acr.22530-BIB0023|acr22530-cit-0023", "doi-asserted-by": "crossref", "first-page": "1033", "DOI": "10.1016/j.jclinepi.2005.10.015", "article-title": "When to use agreement versus reliability measures", "volume": "59", "author": "Vet", "year": "2006", "journal-title": "J Clin Epidemiol"}, {"key": "10.1002/acr.22530-BIB0024|acr22530-cit-0024", "doi-asserted-by": "crossref", "first-page": "96", "DOI": "10.1016/j.jclinepi.2010.03.002", "article-title": "Guidelines for reporting reliability and agreement studies (GRRAS) were proposed", "volume": "64", "author": "Kottner", "year": "2011", "journal-title": "J Clin Epidemiol"}, {"key": "10.1002/acr.22530-BIB0025|acr22530-cit-0025", "doi-asserted-by": "crossref", "first-page": "1331", "DOI": "10.1097/01.brs.0000164099.92112.29", "article-title": "Responsiveness of the numeric pain rating scale in patients with low back pain", "volume": "30", "author": "Childs", "year": "2005", "journal-title": "Spine (Phila Pa 1976)"}, {"key": "10.1002/acr.22530-BIB0026|acr22530-cit-0026", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.1016/S0304-3959(01)00349-9", "article-title": "Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale", "volume": "94", "author": "Farrar", "year": "2001", "journal-title": "Pain"}, {"key": "10.1002/acr.22530-BIB0027|acr22530-cit-0027", "doi-asserted-by": "crossref", "first-page": "283", "DOI": "10.1016/j.ejpain.2003.09.004", "article-title": "Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale", "volume": "8", "author": "Salaffi", "year": "2004", "journal-title": "Eur J Pain"}], "container-title": ["Arthritis Care & Research"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.22530", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.22530", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/acr.22530", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 5]], "date-time": "2018-08-05T22:48:22Z", "timestamp": 1533509302000}, "score": 26.211384, "subtitle": ["Reliability of Patient Reports of Pain Intensity"], "issued": {"date-parts": [[2015, 5]]}, "references-count": 27, "journal-issue": {"published-print": {"date-parts": [[2015, 5]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1002/acr.22530", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["2151-464X"], "issn-type": [{"value": "2151-464X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:39:35Z", "timestamp": 1574113175388}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2000, 2, 1]], "date-time": "2000-02-01T00:00:00Z", "timestamp": 949363200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Hum Hypertens"], "published-print": {"date-parts": [[2000, 2]]}, "DOI": "10.1038/sj.jhh.1000949", "type": "journal-article", "created": {"date-parts": [[2002, 9, 4]], "date-time": "2002-09-04T17:38:33Z", "timestamp": 1031161113000}, "page": "83-90", "source": "Crossref", "is-referenced-by-count": 136, "title": ["Fifty years of Framingham Study contributions to understanding hypertension"], "prefix": "10.1038", "volume": "14", "author": [{"given": "WB", "family": "Kannel", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2000, 2, 21]]}, "container-title": ["Journal of Human Hypertension"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/1000949.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1000949", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1000949.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 18]], "date-time": "2019-03-18T04:36:31Z", "timestamp": 1552883791000}, "score": 24.348747, "issued": {"date-parts": [[2000, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2000, 2]]}, "issue": "2"}, "alternative-id": ["BF1000949"], "URL": "http://dx.doi.org/10.1038/sj.jhh.1000949", "ISSN": ["0950-9240", "1476-5527"], "issn-type": [{"value": "0950-9240", "type": "print"}, {"value": "1476-5527", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T09:24:37Z", "timestamp": 1574328277725}, "publisher-location": "Totowa, NJ", "reference-count": 64, "publisher": "Humana Press", "isbn-type": [{"value": "9781588291974", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1007/978-1-59259-911-0_23", "type": "book-chapter", "created": {"date-parts": [[2007, 11, 4]], "date-time": "2007-11-04T00:39:57Z", "timestamp": 1194136797000}, "page": "471-489", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Management of Hypertension in Older Patients With Arthritis"], "prefix": "10.1007", "author": [{"given": "Sumeska", "family": "Thavarajah", "sequence": "first", "affiliation": []}, {"given": "William B.", "family": "White", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "23_CR1", "first-page": "1383", "volume-title": "Textbook of Rheumatology", "author": "K. Brandt", "year": "1997", "unstructured": "Brandt K. Osteoarthritis: clinical patterns and pathology. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CE, eds. Textbook of Rheumatology. 5th ed. Philadelphia: Saunders; 1997:1383.", "edition": "5th ed."}, {"key": "23_CR2", "doi-asserted-by": "publisher", "first-page": "311", "DOI": "10.1016/0021-9681(86)90053-6", "volume": "39", "author": "A.J. Hartz", "year": "1986", "unstructured": "Hartz AJ, Fischer MG, Bril G, et al. The association of obesity with joint pain and osteoarthritis is the HANES data. J Chronic Dis 1986;39:311.", "journal-title": "J Chronic Dis"}, {"key": "23_CR3", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1136/ard.25.1.1", "volume": "25", "author": "J.S. Lawrence", "year": "1966", "unstructured": "Lawrence JS, Bremner JM, Bier F. Osteoarthritis prevalence in the population and relationships between symptoms and X-ray changes. Ann Rheum Dis 1966;25:1.", "journal-title": "Ann Rheum Dis"}, {"key": "23_CR4", "doi-asserted-by": "publisher", "first-page": "778", "DOI": "10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V", "volume": "41", "author": "R.C. Lawrence", "year": "1998", "unstructured": "Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778\u2013799.", "journal-title": "Arthritis Rheum"}, {"key": "23_CR5", "doi-asserted-by": "publisher", "first-page": "613", "DOI": "10.1038/sj.jhh.1001235", "volume": "15", "author": "H. Celis", "year": "2001", "unstructured": "Celis H, Thijs L, Staessen JA, et al. for Syst-Eur Investigators. Interaction between nonsteroidal antiinflammatory drug intake and calcium channel blocker-based anti-hypertensive treatment in the Syst-Eur Trial. J Hum Hypertens 2001; 15:613\u2013618.", "journal-title": "J Hum Hypertens"}, {"key": "23_CR6", "doi-asserted-by": "publisher", "first-page": "775", "DOI": "10.1016/S0002-9149(97)00514-6", "volume": "80", "author": "G.A. Fierro-Carrion", "year": "1997", "unstructured": "Fierro-Carrion GA, Ram CVS. Nonsteroidal anti-inflammatory drugs (NSAIDs) and blood pressure. Am J Cardiol 1997;80:775\u2013776.", "journal-title": "Am J Cardiol"}, {"key": "23_CR7", "doi-asserted-by": "publisher", "first-page": "781", "DOI": "10.1001/jama.272.10.781", "volume": "272", "author": "J.H. Gurwitz", "year": "1994", "unstructured": "Gurwitz JH, Avorn J, Bohn RL, et al. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA 1994;272:781\u2013786.", "journal-title": "JAMA"}, {"key": "23_CR8", "doi-asserted-by": "crossref", "first-page": "507", "DOI": "10.1111/j.1532-5415.1999.tb02561.x", "volume": "47", "author": "T.S. Field", "year": "1999", "unstructured": "Field TS, Gurwitz JH, Glynn RJ, et al. The renal effects of nonsteroidal anti-inflammatory drugs in older people: findings from the established populations for epidemiologic studies of the elderly. J Am Geriatr Soc 1999;47:507\u2013511.", "journal-title": "J Am Geriatr Soc"}, {"key": "23_CR9", "doi-asserted-by": "publisher", "first-page": "2029", "DOI": "10.1056/NEJM199312303292710", "volume": "329", "author": "W.A. Ray", "year": "1993", "unstructured": "Ray WA, Griffin MR, Avorn J. Evaluating drugs after their approval for clinical use. N Engl J Med 1993;329:2029\u20132032.", "journal-title": "N Engl J Med"}, {"key": "23_CR10", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.7326/0003-4819-121-4-199408150-00011", "volume": "121", "author": "A.G. Johnson", "year": "1994", "unstructured": "Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? Ann Intern Med 1994;121:289\u2013300.", "journal-title": "Ann Intern Med"}, {"key": "23_CR11", "doi-asserted-by": "publisher", "first-page": "17", "DOI": "10.2165/00002512-199812010-00003", "volume": "12", "author": "A.G. Johnson", "year": "1998", "unstructured": "Johnson AG. NSAIDs and blood pressure. Clinical Importance for older patients. Drugs Aging 1998; 12:17\u201327.", "journal-title": "Drugs Aging"}, {"key": "23_CR12", "doi-asserted-by": "publisher", "first-page": "8", "DOI": "10.1093/ageing/17.1.8", "volume": "17", "author": "F.A. Ouweland van den", "year": "1988", "unstructured": "van den Ouweland FA, Gribnau FWJ, Meyboom RHB. Congestive heart failure due to nonsteroidal antiinflammatory drugs in the elderly. Age Ageing 1988;17:8\u201316.", "journal-title": "Age Ageing"}, {"key": "23_CR13", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.2165/00002512-199609050-00005", "volume": "9", "author": "W. Ailabouni", "year": "1996", "unstructured": "Ailabouni W, Eknoyan G. Nonsteroidal anti-inflammatory drugs and acute renal failure in the elderly. A risk-benefit assessment. Drugs Aging 1996;9:341\u2013351.", "journal-title": "Drugs Aging"}, {"key": "23_CR14", "doi-asserted-by": "publisher", "first-page": "8S", "DOI": "10.1016/S0002-9343(98)00069-2", "volume": "105", "author": "D.J. Bjorkman", "year": "1998", "unstructured": "Bjorkman DJ. The effect of aspirin and nonsteroidal anti-inflammatory drugs on prostaglandins. Am J Med 1998;105:8S\u201312S.", "journal-title": "Am J Med"}, {"key": "23_CR15", "doi-asserted-by": "publisher", "first-page": "1520", "DOI": "10.1056/NEJM200011233432103", "volume": "343", "author": "C. Bombardier", "year": "2000", "unstructured": "Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000;343:1520\u20131528.", "journal-title": "N Engl J Med"}, {"key": "23_CR16", "doi-asserted-by": "publisher", "first-page": "37S", "DOI": "10.1016/S0002-9343(99)00115-1", "volume": "106", "author": "L.S. Simon", "year": "1999", "unstructured": "Simon LS. Role and regulation of cyclooxygenase-2 during inflammation. Am J Med 1999;106:37S\u201342S.", "journal-title": "Am J Med"}, {"key": "23_CR17", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.1161/01.HYP.25.3.305", "volume": "25", "author": "V.L. Burt", "year": "1995", "unstructured": "Burt VL, Whelton P, Rocella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey 1988\u20131991. Hypertension 1995;25:305\u2013313.", "journal-title": "Hypertension"}, {"key": "23_CR18", "first-page": "72", "volume": "15", "author": "E.B. Clyburn", "year": "1995", "unstructured": "Clyburn EB, DiPette DJ. Hypertension induced by drugs and other substances. Semin Nephrol 1995;15:72\u201386.", "journal-title": "Semin Nephrol"}, {"key": "23_CR19", "first-page": "40", "volume": "100", "author": "J.L. Kozuh", "year": "2000", "unstructured": "Kozuh JL. NSAIDs and antihypertensives: an unhappy union. Am J Nurs 2000; 100:40\u201343.", "journal-title": "Am J Nurs"}, {"key": "23_CR20", "doi-asserted-by": "crossref", "first-page": "277", "DOI": "10.2165/00002018-199717050-00001", "volume": "17", "author": "A.G. Johnson", "year": "1997", "unstructured": "Johnson AG. NSAIDs and increased blood pressure. What is the clinical significance? Drug Safety 1997;17:277\u2013289.", "journal-title": "Drug Safety"}, {"key": "23_CR21", "doi-asserted-by": "crossref", "first-page": "M91", "DOI": "10.1093/geronj/48.3.M91", "volume": "48", "author": "E.A. Chrischilles", "year": "1993", "unstructured": "Chrischilles EA, Wallace RB. Nonsteroidal anti-inflammatory drugs and blood pressure in an elderly population. J Gerontol 1993;48:M91\u2013M96.", "journal-title": "J Gerontol"}, {"key": "23_CR22", "doi-asserted-by": "publisher", "first-page": "477", "DOI": "10.1001/archinte.153.4.477", "volume": "153", "author": "J.E. Pope", "year": "1993", "unstructured": "Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 1993;153:477\u2013484.", "journal-title": "Arch Intern Med"}, {"key": "23_CR23", "unstructured": "Schitzer TJ, Kivitz AJ, Greenwald M, et al. Rofecoxib provides superior relief of symptoms of osteoarthritis (OA) compared to celecoxib. Presented at: EULAR; June 2001; Prague, Czech Republic. Abstract SAT0089."}, {"key": "23_CR24", "unstructured": "Schwartz JI, Malice MP, Lasseter KC, et al. Effect of rofecoxib, celecoxib, and naproxen on blood pressure and urinary sodium excretion in elderly volunteers. Presented at: EULAR; June 2001; Prague Czech Republic. Abstract SAT0055.", "DOI": "10.1016/S0895-7061(01)01606-5", "doi-asserted-by": "crossref"}, {"key": "23_CR25", "doi-asserted-by": "publisher", "first-page": "18D", "DOI": "10.1016/S0002-9149(02)02233-6", "volume": "89", "author": "W.H. Frishman", "year": "2002", "unstructured": "Frishman WH. Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema. Am J Cardiol 2002;89(suppl):18D\u201325D.", "journal-title": "Am J Cardiol"}, {"key": "23_CR26", "first-page": "319", "volume": "2", "author": "R.D. Brook", "year": "2000", "unstructured": "Brook RD, Kramer MB, Blaxall BC, et al. Nonsteroidal anti-inflammatory drugs and hypertension. J Clin Hypertens 2000;2:319\u2013325.", "journal-title": "J Clin Hypertens"}, {"key": "23_CR27", "doi-asserted-by": "publisher", "first-page": "76", "DOI": "10.1016/S0009-9236(99)70056-1", "volume": "66", "author": "J. Rossat", "year": "1999", "unstructured": "Rossat J, Maillard M, Nussberger J, et al. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin Pharmacol Ther 1999;66:76\u201384.", "journal-title": "Clin Pharmacol Ther"}, {"key": "23_CR28", "first-page": "735", "volume": "289", "author": "F. Catella-Lawson", "year": "1999", "unstructured": "Catella-Lawson F, McAdam B, Morrison BW, et al. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther 1999;289:735\u2013741.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "23_CR29", "first-page": "257", "volume": "10", "author": "A.G. Johnson", "year": "1996", "unstructured": "Johnson AG, Nguyen TV, Owe-Young R, et al. Potential mechanisms by which nonsteroidal anti-inflammatory drugs elevate blood pressure: the role of endothelin-1. J Hum Hypertens 1996;10:257\u2013261.", "journal-title": "J Hum Hypertens"}, {"key": "23_CR30", "doi-asserted-by": "publisher", "first-page": "56", "DOI": "10.1016/0002-9343(86)90932-0", "volume": "80", "author": "J.S. Stoff", "year": "1986", "unstructured": "Stoff JS. Prostaglandins and hypertension. Am J Med 1986;80(suppl):56\u201361.", "journal-title": "Am J Med"}, {"key": "23_CR31", "doi-asserted-by": "publisher", "first-page": "90S", "DOI": "10.1016/S0895-7061(01)02075-1", "volume": "14", "author": "C. Moreno", "year": "2001", "unstructured": "Moreno C, Maier KG, Hoagland KM, et al. Abnormal pressure natriuresis in hypertension: role of cytochrome P450 metabolites of arachidonic acid. Am J Hypertens 2001;14:90S\u201397S.", "journal-title": "Am J Hypertens"}, {"key": "23_CR32", "doi-asserted-by": "publisher", "first-page": "852", "DOI": "10.1016/S0140-6736(94)92827-4", "volume": "344", "author": "W.G. Haynes", "year": "1994", "unstructured": "Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994;344:852\u2013854.", "journal-title": "Lancet"}, {"key": "23_CR33", "doi-asserted-by": "publisher", "first-page": "1023", "DOI": "10.1172/JCI115915", "volume": "90", "author": "J.D. Firth", "year": "1992", "unstructured": "Firth JD, Ratcliffe PJ. Organ distribution of three rat endothelin messenger RNA\u2019s and the effects of ischemia in renal gene expression. J Clin Invest 1992;90:1023\u20131031.", "journal-title": "J Clin Invest"}, {"key": "23_CR34", "doi-asserted-by": "publisher", "first-page": "272", "DOI": "10.1073/pnas.96.1.272", "volume": "96", "author": "B.F. McAdam", "year": "1999", "unstructured": "McAdam BF, Catella-Lawson IA, Mardini S, et al. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA 1999;96:272\u2013277.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "23_CR35", "doi-asserted-by": "crossref", "first-page": "M74", "DOI": "10.1093/gerona/51A.2.M74", "volume": "51", "author": "J.H. Gurwitz", "year": "1996", "unstructured": "Gurwitz JH, Everett DE, Monane M, et al. The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons. J Gerontol A Biol Sci Med Sci 1996;51:M74\u2013M79.", "journal-title": "J Gerontol A Biol Sci Med Sci"}, {"key": "23_CR36", "doi-asserted-by": "publisher", "first-page": "1161", "DOI": "10.1016/S0895-7061(00)01204-8", "volume": "13", "author": "T.O. Morgan", "year": "2000", "unstructured": "Morgan TO, Anderson A, Bertram D. Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. Am J Hypertens 2000; 13:1161\u20131167.", "journal-title": "Am J Hypertens"}, {"key": "23_CR37", "first-page": "244", "volume": "15", "author": "P. Mene", "year": "1995", "unstructured": "Mene P, Pugliese F, Patrono C. The effects of nonsteroidal anti-inflammatory drugs on human hypertensive vascular disease. Semin Nephrol 1995;15:244\u2013252.", "journal-title": "Semin Nephrol"}, {"key": "23_CR38", "doi-asserted-by": "publisher", "first-page": "1967", "DOI": "10.1001/jama.283.15.1967", "volume": "283", "author": "ALLHAT Collaborative Research Group.", "year": "2000", "unstructured": "ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2000;283: 1967\u20131975.", "journal-title": "JAMA"}, {"key": "23_CR39", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.2165/00003495-199651020-00001", "volume": "51", "author": "P.W. DeLeeuw", "year": "1996", "unstructured": "DeLeeuw PW. Nonsteroidal anti-inflammatory drugs and hypertension. The risks in perspective. Drugs 1996;51:179\u2013187.", "journal-title": "Drugs"}, {"issue": "15 suppl", "key": "23_CR40", "first-page": "S401", "volume": "8", "author": "S.Z. Zhao", "year": "2002", "unstructured": "Zhao SZ, Burke TA, Whelton A, et al. Blood pressure destabilization and related health care utilization among hypertensive patients using nonspecific NSAIDs and COX-2 inhibitors. Am J Manag Care 2002;8(15 suppl):S401\u2013S413.", "journal-title": "Am J Manag Care"}, {"key": "23_CR41", "doi-asserted-by": "publisher", "first-page": "1247", "DOI": "10.1001/jama.284.10.1247", "volume": "284", "author": "F.E. Silverstein", "year": "2000", "unstructured": "Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomised controlled trial Celecoxib Long-Term Arthritis Safety Study. JAMA 2000;284:1247\u20131255.", "journal-title": "JAMA"}, {"key": "23_CR42", "doi-asserted-by": "crossref", "first-page": "322", "DOI": "10.1002/cpt1979253322", "volume": "25", "author": "D.C. Brater", "year": "1979", "unstructured": "Brater DC. Effect of indomethacin on salt and water homeostasis. Clin Pharmacol Ther 1979;25:322\u2013330.", "journal-title": "Clin Pharmacol Ther"}, {"issue": "suppl 6A", "key": "23_CR43", "doi-asserted-by": "publisher", "first-page": "65S", "DOI": "10.1016/S0002-9343(99)00369-1", "volume": "107", "author": "D.C. Brater", "year": "1999", "unstructured": "Brater DC. Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2 selective inhibition. Am J Med 1999; 107(suppl 6A): 65S\u201371S.", "journal-title": "Am J Med"}, {"key": "23_CR44", "doi-asserted-by": "publisher", "first-page": "489", "DOI": "10.1016/S0749-0690(05)70082-3", "volume": "17", "author": "G.M. Bell", "year": "2001", "unstructured": "Bell GM, Schnitzer TJ. COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of pain in the elderly. Clin Geriatr Med 2001;17:489\u2013502.", "journal-title": "Clin Geriatr Med"}, {"key": "23_CR45", "doi-asserted-by": "publisher", "first-page": "89", "DOI": "10.1097/00041552-200101000-00014", "volume": "10", "author": "M.D. Breyer", "year": "2001", "unstructured": "Breyer MD, Harris RC. Cyclooxygenase 2 and the kidney. Curr Opin Nephrol Hypertens 2001;10:89\u201398.", "journal-title": "Curr Opin Nephrol Hypertens"}, {"key": "23_CR46", "first-page": "F706", "volume": "277", "author": "T.R. Traynor", "year": "1999", "unstructured": "Traynor TR, Smart A, Briggs JP, et al. Inhibition of macula densa-stimulated renin secretion by pharmacological blockade of cyclooxygenase-2. Am J Physiol 1999;277:F706\u2013F710.", "journal-title": "Am J Physiol"}, {"key": "23_CR47", "doi-asserted-by": "publisher", "first-page": "63", "DOI": "10.1097/00045391-200007020-00004", "volume": "7", "author": "A. Whelton", "year": "2000", "unstructured": "Whelton A. Renal and related cardiovascular effects of conventional and COX-2 specific NSAIDs and non-NSAID analgesics. Am J Ther 2000;7:63\u201374.", "journal-title": "Am J Ther"}, {"key": "23_CR48", "doi-asserted-by": "publisher", "first-page": "433", "DOI": "10.1056/NEJM200108093450607", "volume": "345", "author": "G.A. Fitzgerald", "year": "2001", "unstructured": "Fitzgerald GA, Patrono C. The COXIBS, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001;345:433\u2013442.", "journal-title": "N Engl J Med"}, {"key": "23_CR49", "doi-asserted-by": "crossref", "first-page": "875", "DOI": "10.1161/01.HYP.21.6.875", "volume": "21", "author": "C. Ferri", "year": "1993", "unstructured": "Ferri C, Bellini C, Piccoli A, et al. Enhanced blood pressure response to cyclooxygenase inhibitor in SMT-sensitive human essential hypertension. Hypertension 1993;21:875\u2013881.", "journal-title": "Hypertension"}, {"key": "23_CR50", "doi-asserted-by": "publisher", "first-page": "777", "DOI": "10.1001/archinte.160.6.777", "volume": "160", "author": "J. Page", "year": "2000", "unstructured": "Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients. An underrecognized public health problem. Arch Intern Med 2000; 160:777\u2013784.", "journal-title": "Arch Intern Med"}, {"key": "23_CR51", "doi-asserted-by": "publisher", "first-page": "85", "DOI": "10.1097/00045391-200103000-00003", "volume": "8", "author": "A. Whelton", "year": "2001", "unstructured": "Whelton A, Fort JG, Puma JG, et al. Cyclooxygenase-2 specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients. Am J Ther 2001;8:85\u201395.", "journal-title": "Am J Ther"}, {"key": "23_CR52", "doi-asserted-by": "publisher", "first-page": "959", "DOI": "10.1016/S0002-9149(02)02661-9", "volume": "90", "author": "A. Whelton", "year": "2002", "unstructured": "Whelton A, White WB, Bello AE, et al. Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or = 65 years of age with systemic hypertension and osteoarthritis. Am J Cardiol 2002;90:959\u2013963.", "journal-title": "Am J Cardiol"}, {"key": "23_CR53", "doi-asserted-by": "publisher", "first-page": "1108", "DOI": "10.1001/archinte.158.10.1108", "volume": "158", "author": "E.R. Heerdink", "year": "1998", "unstructured": "Heerdink ER, Leufkens HG, Herings RM, et al. NSAIDs associated with risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med 1998;158:1108\u20131112.", "journal-title": "Arch Intern Med"}, {"key": "23_CR54", "doi-asserted-by": "publisher", "first-page": "82", "DOI": "10.1185/030079902125000354", "volume": "18", "author": "B.J. Gertz", "year": "2002", "unstructured": "Gertz BJ, Krupa D, Bolognese JA, et al. A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator nonselective nonsteroidal anti-inflammatory agents. Curr Med Res Opin 2002;18:82\u201391.", "journal-title": "Curr Med Res Opin"}, {"key": "23_CR55", "doi-asserted-by": "publisher", "first-page": "393", "DOI": "10.1097/00075198-200112000-00005", "volume": "7", "author": "M.D. Breyer", "year": "2001", "unstructured": "Breyer MD, Hao C, Qi Z. Cyclooxygenase-2 Selective inhibitors and the kidney. Curr Opin Crit Care 2001;7:393\u2013400.", "journal-title": "Curr Opin Crit Care"}, {"key": "23_CR56", "doi-asserted-by": "crossref", "first-page": "783", "DOI": "10.7326/0003-4819-90-5-783", "volume": "90", "author": "S.Y. Tan", "year": "1979", "unstructured": "Tan SY, Shapiro R, Franco R, et al. Indomethacin induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism. Ann Intern Med 1979;90:783\u2013785.", "journal-title": "Ann Intern Med"}, {"key": "23_CR57", "doi-asserted-by": "publisher", "first-page": "13S", "DOI": "10.1016/S0002-9343(99)00113-8", "volume": "106", "author": "A. Whelton", "year": "1999", "unstructured": "Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999; 106:13S\u201324S.", "journal-title": "Am J Med"}, {"key": "23_CR58", "doi-asserted-by": "publisher", "first-page": "53S", "DOI": "10.1016/S0002-9343(98)00074-6", "volume": "105", "author": "G. Ruoff", "year": "1998", "unstructured": "Ruoff G. Management of pain in patients with multiple health problems: a guide for the practicing physician. Am J Med 1998;105:53S\u201360S.", "journal-title": "Am J Med"}, {"key": "23_CR59", "doi-asserted-by": "publisher", "first-page": "55", "DOI": "10.1097/00045391-199701000-00011", "volume": "4", "author": "M.G. Atta", "year": "1997", "unstructured": "Atta MG, Whelton A. Acute papillary necrosis caused by ibuprofen. Am J Ther 1997;4:55\u201360.", "journal-title": "Am J Ther"}, {"key": "23_CR60", "doi-asserted-by": "publisher", "first-page": "1465", "DOI": "10.1001/archinte.160.10.1465", "volume": "160", "author": "A. Whelton", "year": "2000", "unstructured": "Whelton A, Schulman G, Wallemark C. Effects of celecoxib and naproxen on renal function in the elderly. Arch Intern Med 2000; 160:1465\u20131471.", "journal-title": "Arch Intern Med"}, {"key": "23_CR61", "doi-asserted-by": "publisher", "first-page": "2068", "DOI": "10.1161/01.CIR.0000127578.21885.3E", "volume": "109", "author": "D.H. Solomon", "year": "2004", "unstructured": "Solomon DH, Schneeweiss S, Glynn RJ, et al. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarciton in older adults. Circulation 2004;109:2068.", "journal-title": "Circulation"}, {"key": "23_CR62", "doi-asserted-by": "publisher", "first-page": "425", "DOI": "10.1016/S0002-9149(01)02265-2", "volume": "89", "author": "W.B. White", "year": "2002", "unstructured": "White WB, Faich G, Whelton A, et al. Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac. Am J Cardiol 2002;89:425\u2013430.", "journal-title": "Am J Cardiol"}, {"key": "23_CR63", "doi-asserted-by": "publisher", "first-page": "411", "DOI": "10.1016/S0002-9149(03)00659-3", "volume": "93", "author": "W.B. White", "year": "2003", "unstructured": "White WB, Faich G, Borer J, Makuch R. Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase inhibitor celecoxib. Am J Cardiol 2003;93:411\u2013418.", "journal-title": "Am J Cardiol"}, {"key": "23_CR64", "doi-asserted-by": "publisher", "first-page": "244", "DOI": "10.1097/01.mjt.0000127360.23508.04", "volume": "11", "author": "W.B. White", "year": "2004", "unstructured": "White WB, Strand V, Whelton A, Roberts R. Effects of the cyclooxygenase-2 specific inhibitor valdecoxib versus nonsteroidal antiinflammatory agents and placebo on cardiovascular thrombotic events in patients with arthritis. Am J Ther 2004; 11:244.", "journal-title": "Am J Ther"}], "container-title": ["Clinical Hypertension and Vascular Diseases", "Hypertension in the Elderly"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-59259-911-0_23", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 4]], "date-time": "2019-05-04T04:44:59Z", "timestamp": 1556945099000}, "score": 24.080763, "issued": {"date-parts": [[null]]}, "ISBN": ["9781588291974"], "references-count": 64, "URL": "http://dx.doi.org/10.1007/978-1-59259-911-0_23", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:41:06Z", "timestamp": 1574113266803}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "8", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1997, 8, 1]], "date-time": "1997-08-01T00:00:00Z", "timestamp": 870393600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Hum Hypertens"], "published-print": {"date-parts": [[1997, 8]]}, "DOI": "10.1038/sj.jhh.1000484", "type": "journal-article", "created": {"date-parts": [[2002, 9, 4]], "date-time": "2002-09-04T17:35:54Z", "timestamp": 1031160954000}, "page": "533-536", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Abrupt, severe hypertension associated with dissection of a renal artery during selective catheterization"], "prefix": "10.1038", "volume": "11", "author": [{"given": "Y Anis", "family": "Anwar", "sequence": "first", "affiliation": []}, {"given": "ED", "family": "Sullivan", "sequence": "additional", "affiliation": []}, {"given": "HH", "family": "Chen", "sequence": "additional", "affiliation": []}, {"given": "WB", "family": "White", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[1997, 12, 18]]}, "container-title": ["Journal of Human Hypertension"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/1000484.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1000484", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1000484.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 17]], "date-time": "2019-03-17T10:30:58Z", "timestamp": 1552818658000}, "score": 23.449799, "issued": {"date-parts": [[1997, 8]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1997, 8]]}, "issue": "8"}, "alternative-id": ["BF1000484"], "URL": "http://dx.doi.org/10.1038/sj.jhh.1000484", "ISSN": ["0950-9240", "1476-5527"], "issn-type": [{"value": "0950-9240", "type": "print"}, {"value": "1476-5527", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:39:17Z", "timestamp": 1574113157366}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2001, 2, 1]], "date-time": "2001-02-01T00:00:00Z", "timestamp": 980985600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Hum Hypertens"], "published-print": {"date-parts": [[2001, 2]]}, "DOI": "10.1038/sj.jhh.1001137", "type": "journal-article", "created": {"date-parts": [[2002, 9, 4]], "date-time": "2002-09-04T17:41:28Z", "timestamp": 1031161288000}, "page": "135-141", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Chronotherapeutic delivery of verapamil in obese versus non-obese patients with essential hypertension"], "prefix": "10.1038", "volume": "15", "author": [{"given": "WB", "family": "White", "sequence": "first", "affiliation": []}, {"given": "WJ", "family": "Elliott", "sequence": "additional", "affiliation": []}, {"given": "MF", "family": "Johnson", "sequence": "additional", "affiliation": []}, {"given": "HR", "family": "Black", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2001, 4, 17]]}, "container-title": ["Journal of Human Hypertension"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/1001137.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1001137", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1001137.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 17]], "date-time": "2019-03-17T10:05:54Z", "timestamp": 1552817154000}, "score": 23.449799, "issued": {"date-parts": [[2001, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2001, 2]]}, "issue": "2"}, "alternative-id": ["BF1001137"], "URL": "http://dx.doi.org/10.1038/sj.jhh.1001137", "ISSN": ["0950-9240", "1476-5527"], "issn-type": [{"value": "0950-9240", "type": "print"}, {"value": "1476-5527", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T06:48:00Z", "timestamp": 1574837280817}, "reference-count": 0, "publisher": "BMJ Publishing Group Ltd and European League Against Rheumatism", "content-domain": {"domain": ["bmj.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2017, 6]]}, "DOI": "10.1136/annrheumdis-2017-eular.5024", "type": "proceedings-article", "created": {"date-parts": [[2017, 9, 19]], "date-time": "2017-09-19T16:40:30Z", "timestamp": 1505839230000}, "update-policy": "http://dx.doi.org/10.1136/crossmarkpolicy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["AB0370\u2005Development of patient preference phenotypes for rheumatoid arthritis"], "prefix": "10.1136", "author": [{"given": "WB", "family": "Nowell", "sequence": "first", "affiliation": []}, {"given": "C", "family": "Wiedmeyer", "sequence": "additional", "affiliation": []}, {"given": "G", "family": "Herath", "sequence": "additional", "affiliation": []}, {"given": "G", "family": "Michel", "sequence": "additional", "affiliation": []}, {"given": "L", "family": "Fraenkel", "sequence": "additional", "affiliation": []}], "member": "239", "published-online": {"date-parts": [[2017, 6, 15]]}, "event": {"name": "Annual European Congress of Rheumatology, 14\u201317 June, 2017"}, "container-title": ["Abstracts Accepted for Publication"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2017-eular.5024", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 9, 19]], "date-time": "2017-09-19T16:56:31Z", "timestamp": 1505840191000}, "score": 22.702269, "issued": {"date-parts": [[2017, 6]]}, "references-count": 0, "alternative-id": ["10.1136/annrheumdis-2017-eular.5024"], "URL": "http://dx.doi.org/10.1136/annrheumdis-2017-eular.5024"}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T08:06:22Z", "timestamp": 1574582782214}, "reference-count": 0, "publisher": "British Academy", "isbn-type": [{"value": "9780197265543", "type": "print"}, {"value": "9780191760358", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2013, 10, 17]]}, "abstract": "<p>The chapter examines aspects of the history and theory of commentary, and places Badius\u2019s own commentary practice within these contexts. It focuses in particular of the tradition of <italic>grammatica</italic> associated with the grammarians of Late Antiquity: Servius, Donatus, Diomedes. The chapter distinguishes between the designations used for different types of humanist commentary in the Renaissance, and narrows the focus to Badius\u2019s own \u2018familiar commentary\u2019 (<italic>familiaris interpretatio</italic>). In his commentaries, on medieval and religious texts as well as on humanist and classical authors, Badius maintained an identifiably \u2018humanist\u2019 approach which was nevertheless firmly grounded in a long tradition of pedagogical commentary, bringing out the moral meanings of a text through a close examination of grammar and style. The chapter examines the defining features of this type of commentary, its composition and uses, and analyses the figurative language Badius used to characterize his commentary text.</p>", "DOI": "10.5871/bacad/9780197265543.003.0003", "type": "book-chapter", "created": {"date-parts": [[2015, 2, 17]], "date-time": "2015-02-17T19:03:44Z", "timestamp": 1424199824000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Defining Commentary"], "prefix": "10.5871", "author": [{"given": "Paul", "family": "White", "sequence": "first", "affiliation": []}], "member": "3895", "published-online": {"date-parts": [[2015, 1, 22]]}, "container-title": ["Jodocus Badius Ascensius"], "original-title": ["Defining Commentary"], "deposited": {"date-parts": [[2018, 10, 24]], "date-time": "2018-10-24T13:47:56Z", "timestamp": 1540388876000}, "score": 21.207989, "issued": {"date-parts": [[2013, 10, 17]]}, "ISBN": ["9780197265543", "9780191760358"], "references-count": 0, "URL": "http://dx.doi.org/10.5871/bacad/9780197265543.003.0003"}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:39:33Z", "timestamp": 1574113173234}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2000, 2, 1]], "date-time": "2000-02-01T00:00:00Z", "timestamp": 949363200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Hum Hypertens"], "published-print": {"date-parts": [[2000, 2]]}, "DOI": "10.1038/sj.jhh.1000950", "type": "journal-article", "created": {"date-parts": [[2002, 9, 4]], "date-time": "2002-09-04T17:38:33Z", "timestamp": 1031161113000}, "page": "151-153", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Coexistence of atherosclerotic renal artery stenosis with primary hyperaldosteronism"], "prefix": "10.1038", "volume": "14", "author": [{"given": "GA", "family": "Mansoor", "sequence": "first", "affiliation": []}, {"given": "BE", "family": "Tendler", "sequence": "additional", "affiliation": []}, {"given": "YA", "family": "Anwar", "sequence": "additional", "affiliation": []}, {"given": "G", "family": "Uwaifo", "sequence": "additional", "affiliation": []}, {"given": "WB", "family": "White", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2000, 2, 21]]}, "container-title": ["Journal of Human Hypertension"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/1000950.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1000950", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1000950.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 18]], "date-time": "2019-03-18T04:36:32Z", "timestamp": 1552883792000}, "score": 21.121891, "issued": {"date-parts": [[2000, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2000, 2]]}, "issue": "2"}, "alternative-id": ["BF1000950"], "URL": "http://dx.doi.org/10.1038/sj.jhh.1000950", "ISSN": ["0950-9240", "1476-5527"], "issn-type": [{"value": "0950-9240", "type": "print"}, {"value": "1476-5527", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T21:10:14Z", "timestamp": 1575321014108}, "reference-count": 33, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2008, 12, 1]], "date-time": "2008-12-01T00:00:00Z", "timestamp": 1228089600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pain Management Nursing"], "published-print": {"date-parts": [[2008, 12]]}, "DOI": "10.1016/j.pmn.2008.02.007", "type": "journal-article", "created": {"date-parts": [[2008, 11, 10]], "date-time": "2008-11-10T08:35:24Z", "timestamp": 1226306124000}, "page": "171-179", "source": "Crossref", "is-referenced-by-count": 17, "title": ["A Goal Attainment Pain Management Program for Older Adults with Arthritis"], "prefix": "10.1016", "volume": "9", "author": [{"given": "Gail C.", "family": "Davis", "sequence": "first", "affiliation": []}, {"given": "Terri L.", "family": "White", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pain Management Nursing"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1524904208000660?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1524904208000660?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 24]], "date-time": "2018-12-24T14:51:27Z", "timestamp": 1545663087000}, "score": 20.965946, "issued": {"date-parts": [[2008, 12]]}, "references-count": 33, "journal-issue": {"published-print": {"date-parts": [[2008, 12]]}, "issue": "4"}, "alternative-id": ["S1524904208000660"], "URL": "http://dx.doi.org/10.1016/j.pmn.2008.02.007", "ISSN": ["1524-9042"], "issn-type": [{"value": "1524-9042", "type": "print"}], "subject": ["Advanced and Specialised Nursing"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T11:11:19Z", "timestamp": 1574161879940}, "reference-count": 25, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pain"], "published-print": {"date-parts": [[1989, 4]]}, "DOI": "10.1016/0304-3959(89)90158-9", "type": "journal-article", "created": {"date-parts": [[2003, 4, 25]], "date-time": "2003-04-25T07:38:38Z", "timestamp": 1051256318000}, "page": "97-101", "source": "Crossref", "is-referenced-by-count": 39, "title": ["Epidural patient-controlled analgesia (PCA): an alternative to continuous epidural infusions"], "prefix": "10.1097", "volume": "37", "author": [{"given": "Steven", "family": "Marlowe", "sequence": "first", "affiliation": []}, {"given": "Ray", "family": "Engstrom", "sequence": "additional", "affiliation": []}, {"given": "Paul F.", "family": "White", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Pain"], "language": "en", "deposited": {"date-parts": [[2017, 6, 15]], "date-time": "2017-06-15T20:56:13Z", "timestamp": 1497560173000}, "score": 20.336369, "subtitle": [""], "issued": {"date-parts": [[1989, 4]]}, "references-count": 25, "journal-issue": {"issue": "1"}, "URL": "http://dx.doi.org/10.1016/0304-3959(89)90158-9", "ISSN": ["0304-3959"], "issn-type": [{"value": "0304-3959", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T16:01:13Z", "timestamp": 1574438473967}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Hypertension"], "published-print": {"date-parts": [[2010, 6]]}, "DOI": "10.1097/01.hjh.0000379505.93273.55", "type": "journal-article", "created": {"date-parts": [[2010, 6, 21]], "date-time": "2010-06-21T05:38:00Z", "timestamp": 1277098680000}, "page": "e429", "source": "Crossref", "is-referenced-by-count": 1, "title": ["RESULTS OF A NOVEL ANGIOTENSIN RECEPTOR BLOCKER, AZILSARTAN MEDOXOMIL, IN PATIENTS WITH PRIMARY HYPERTENSION: 9A.01"], "prefix": "10.1097", "volume": "28", "author": [{"given": "G", "family": "Bakris", "sequence": "first", "affiliation": []}, {"given": "D", "family": "Sica", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Weber", "sequence": "additional", "affiliation": []}, {"given": "WB", "family": "White", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Perez", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Cao", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Kupfer", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Journal of Hypertension"], "language": "en", "link": [{"URL": "http://journals.lww.com/jhypertension/Fulltext/10.1097/01.hjh.0000379505.93273.55", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 29]], "date-time": "2018-11-29T14:00:45Z", "timestamp": 1543500045000}, "score": 20.293102, "subtitle": [""], "issued": {"date-parts": [[2010, 6]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1097/01.hjh.0000379505.93273.55", "ISSN": ["0263-6352"], "issn-type": [{"value": "0263-6352", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T11:46:57Z", "timestamp": 1574336817107}, "reference-count": 72, "publisher": "Springer Science and Business Media LLC", "issue": "6", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2007, 12, 1]], "date-time": "2007-12-01T00:00:00Z", "timestamp": 1196467200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Current Science Inc"], "published-print": {"date-parts": [[2007, 12]]}, "DOI": "10.1007/s11916-007-0229-x", "type": "journal-article", "created": {"date-parts": [[2007, 12, 6]], "date-time": "2007-12-06T16:09:18Z", "timestamp": 1196957358000}, "page": "428-435", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Cardiovascular risk, hypertension, and NSAIDs"], "prefix": "10.1007", "volume": "11", "author": [{"given": "William B.", "family": "White", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2007, 12, 5]]}, "reference": [{"key": "229_CR1", "doi-asserted-by": "crossref", "first-page": "1247", "DOI": "10.1001/jama.284.10.1247", "volume": "284", "author": "F.E. Silverstein", "year": "2000", "unstructured": "Silverstein FE, Faich G, Goldstein JL, et al.: Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: a randomized controlled trial. JAMA 2000, 284:1247\u20131255.", "journal-title": "JAMA"}, {"key": "229_CR2", "doi-asserted-by": "crossref", "first-page": "1520", "DOI": "10.1056/NEJM200011233432103", "volume": "343", "author": "C. Bombardier", "year": "2000", "unstructured": "Bombardier C, Laine L, Reicin A, et al.: Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000, 343:1520\u20131528.", "journal-title": "N Engl J Med"}, {"key": "229_CR3", "doi-asserted-by": "crossref", "first-page": "954", "DOI": "10.1001/jama.286.8.954", "volume": "286", "author": "D. Mukherjee", "year": "2001", "unstructured": "Mukherjee D, Nissen SE, Topol EJ: Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001, 286:954\u2013959.", "journal-title": "JAMA"}, {"key": "229_CR4", "doi-asserted-by": "crossref", "first-page": "2280", "DOI": "10.1161/hc4401.100078", "volume": "104", "author": "M.A. Konstam", "year": "2001", "unstructured": "Konstam MA, Weir MR, Reicin A, et al.: Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib. Circulation 2001, 104:2280\u20132288.", "journal-title": "Circulation"}, {"key": "229_CR5", "doi-asserted-by": "crossref", "first-page": "1092", "DOI": "10.1056/NEJMoa050493", "volume": "352", "author": "R.S. Bresalier", "year": "2005", "unstructured": "Bresalier RS, Sandler RS, Quan H, et al.: Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005, 352:1092\u20131102.", "journal-title": "N Engl J Med"}, {"key": "229_CR6", "doi-asserted-by": "crossref", "first-page": "1081", "DOI": "10.1056/NEJMoa050330", "volume": "352", "author": "N.A. Nussmeier", "year": "2005", "unstructured": "Nussmeier NA, Whelton AA, Brown MT, et al.: Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 2005, 352:1081\u20131091.", "journal-title": "N Engl J Med"}, {"key": "229_CR7", "doi-asserted-by": "crossref", "first-page": "698", "DOI": "10.1038/9550", "volume": "5", "author": "D.W. Gilroy", "year": "1999", "unstructured": "Gilroy DW, Colville-Nash PR, Willis D, et al.: Inducible cyclooygenase may have anti-inflammatory properties. Nat Med 1999, 5:698\u2013701.", "journal-title": "Nat Med"}, {"key": "229_CR8", "doi-asserted-by": "crossref", "first-page": "3147", "DOI": "10.2174/0929867043363668", "volume": "11", "author": "W. Kiefer", "year": "2004", "unstructured": "Kiefer W, Dannhardt G: Novel insights and therapeutic applications in the field of inhibitors of COX-2. Curr Med Chem 2004, 11:3147\u20133161.", "journal-title": "Curr Med Chem"}, {"key": "229_CR9", "doi-asserted-by": "crossref", "first-page": "431", "DOI": "10.1080/10408360091174286", "volume": "37", "author": "E. Fosslien", "year": "2000", "unstructured": "Fosslien E: Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia. Crit Rev Clin Lab Sci 2000, 37:431\u2013502.", "journal-title": "Crit Rev Clin Lab Sci"}, {"key": "229_CR10", "doi-asserted-by": "crossref", "first-page": "396", "DOI": "10.1161/01.HYP.0000140925.73081.4c", "volume": "44", "author": "C.M. Hao", "year": "2004", "unstructured": "Hao CM, Breyer MD: Hypertension and cyclooxygenase inhibitors. Target: The renal medulla. Hypertension 2004, 44:396\u2013397.", "journal-title": "Hypertension"}, {"key": "229_CR11", "doi-asserted-by": "crossref", "first-page": "543", "DOI": "10.1111/j.1365-201X.2004.01329.x", "volume": "181", "author": "R.C. Harris", "year": "2004", "unstructured": "Harris RC, Zhang MZ, Cheng HF: Cyclooxygenase-2 and the renal angiotensin system. Acta Physiol Scand 2004, 181:543\u2013547.", "journal-title": "Acta Physiol Scand"}, {"key": "229_CR12", "unstructured": "Fries S, Grosser T: The cardiovascular pharmacology of COX-2 inhibition. Hematology Am Soc Hematol Educ Program 2005:445\u201351.", "DOI": "10.1182/asheducation-2005.1.445", "doi-asserted-by": "crossref"}, {"key": "229_CR13", "doi-asserted-by": "crossref", "first-page": "1240", "DOI": "10.1161/01.RES.0000170888.11669.28", "volume": "96", "author": "R.D. Rudic", "year": "2005", "unstructured": "Rudic RD, Brinster D, Cheng Y, et al.: COX-2-derived prostacyclin modulates vascular remodeling. Circ Res 2005, 96:1240\u20131247.", "journal-title": "Circ Res"}, {"key": "229_CR14", "doi-asserted-by": "crossref", "first-page": "334", "DOI": "10.1161/01.CIR.0000153386.95356.78", "volume": "111", "author": "K.M. Egan", "year": "2005", "unstructured": "Egan KM, Wang M, Lucin MB, et al.: Cyclooxygenases, thromboxane, and atherosclerosis: Plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism. Circulation 2005, 111:334\u2013342.", "journal-title": "Circulation"}, {"key": "229_CR15", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1016/j.cmet.2005.08.005", "volume": "2", "author": "H. Francois", "year": "2005", "unstructured": "Francois H, Athirakul K, Howell D, et al.: Prostacyclin protects againsts elevated blood pressure and cardiac fibrosis. Cell Metab 2005, 2:201\u2013207.", "journal-title": "Cell Metab"}, {"key": "229_CR16", "doi-asserted-by": "crossref", "first-page": "e1", "DOI": "10.1161/01.RES.0000153150.27690.f2", "volume": "96", "author": "K. Rabausch", "year": "2005", "unstructured": "Rabausch K, Bretschneider E, Sarbia M, et al.: Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2 derived prostaglandins. Circ Res 2005, 96:e1\u2013e6.", "journal-title": "Circ Res"}, {"key": "229_CR17", "doi-asserted-by": "crossref", "first-page": "506", "DOI": "10.1016/S0008-6363(02)00414-5", "volume": "55", "author": "R. Bolli", "year": "2002", "unstructured": "Bolli R, Shinmura K, Tang XL: Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of pre-conditioning. Cardiovasc Res 2002, 55:506\u2013519.", "journal-title": "Cardiovasc Res"}, {"key": "229_CR18", "doi-asserted-by": "crossref", "first-page": "759", "DOI": "10.1161/CIRCULATIONAHA.105.568451", "volume": "112", "author": "E.M. Antman", "year": "2005", "unstructured": "Antman EM, DeMets D, Loscalzo J: Cyclooxygenase inhibition and CV risk. Circulation 2005, 112:759\u2013770.", "journal-title": "Circulation"}, {"key": "229_CR19", "doi-asserted-by": "crossref", "first-page": "945", "DOI": "10.1124/jpet.104.077644", "volume": "312", "author": "A. Virdis", "year": "2005", "unstructured": "Virdis A, Colucci R, Fornai M, et al.: Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: Role of inducible nitric-oxide synthase and oxidative stress. J Pharmacol Exp Ther 2005, 312:945\u2013953.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "229_CR20", "doi-asserted-by": "crossref", "first-page": "1685", "DOI": "10.1161/01.CIR.0000160358.63804.C9", "volume": "111", "author": "J. Steffel", "year": "2005", "unstructured": "Steffel J, Hermann M, Greutert H, et al.: Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation. Circulation 2005, 111:1685\u20131689.", "journal-title": "Circulation"}, {"key": "229_CR21", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1001/archinte.165.2.161", "volume": "165", "author": "J.R. Sowers", "year": "2005", "unstructured": "Sowers JR, White WB, Pitt B, et al.: The effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis and type 2 diabetes. Arch Intern Med 2005, 165:161\u2013168.", "journal-title": "Arch Intern Med"}, {"key": "229_CR22", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1001/archinte.1993.00410040045007", "volume": "153", "author": "J.E. Pope", "year": "1993", "unstructured": "Pope JE, Anderson JJ, Felson DT: A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 1993, 153:477\u2013484.", "journal-title": "Arch Intern Med"}, {"key": "229_CR23", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.7326/0003-4819-121-4-199408150-00011", "volume": "121", "author": "A.G. Johnson", "year": "1994", "unstructured": "Johnson AG, Nguyen TV, Day RO: Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994, 121:289\u2013300.", "journal-title": "Ann Intern Med"}, {"key": "229_CR24", "doi-asserted-by": "crossref", "first-page": "92", "DOI": "10.1161/01.HYP.0000149684.01903.b8", "volume": "45", "author": "S.A. Grover", "year": "2005", "unstructured": "Grover SA, Coupal L, Zowall H: Treating osteoarthritis with cyclooxygenase-2 specific inhibitors: What are the benefits of avoiding blood pressure destabilization? Hypertension 2005, 45:92\u201397.", "journal-title": "Hypertension"}, {"key": "229_CR25", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.1001/archinte.160.2.149", "volume": "160", "author": "W.B. White", "year": "2000", "unstructured": "White WB: Benefits of antihypertensive therapy in older patients with hypertension. Arch Intern Med 2000, 160:149\u2013150.", "journal-title": "Arch Intern Med"}, {"key": "229_CR26", "doi-asserted-by": "crossref", "first-page": "1967", "DOI": "10.1001/jama.283.15.1967", "volume": "283", "author": "ALLHAT OfficersCoordinators for the ALLHAT Collaborative Research Group.", "year": "2000", "unstructured": "ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2000, 283:1967\u20131975.", "journal-title": "JAMA"}, {"key": "229_CR27", "doi-asserted-by": "crossref", "first-page": "2022", "DOI": "10.1016/S0140-6736(04)16451-9", "volume": "363", "author": "S. Julius", "year": "2004", "unstructured": "Julius S, Kjeldsen SE, Weber M, et al.: Outcomes in hypertensive patients at high CV risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004, 363:2022\u20132031.", "journal-title": "Lancet"}, {"key": "229_CR28", "doi-asserted-by": "crossref", "first-page": "1161", "DOI": "10.1016/S0895-7061(00)01204-8", "volume": "13", "author": "T.O. Morgan", "year": "2000", "unstructured": "Morgan TO, Anderson A, Bertram D: Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. Am J Hypertens 2000, 13:1161\u20131167.", "journal-title": "Am J Hypertens"}, {"key": "229_CR29", "doi-asserted-by": "crossref", "first-page": "50", "DOI": "10.1067/mcp.2002.126182", "volume": "72", "author": "J.I. Schwartz", "year": "2002", "unstructured": "Schwartz JI, Vandormael K, Malice MP, et al.: Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin Pharmacol Ther 2002, 72:50\u201361.", "journal-title": "Clin Pharmacol Ther"}, {"key": "229_CR30", "first-page": "1501", "volume": "29", "author": "L.S. Simon", "year": "2002", "unstructured": "Simon LS, Smolen JS, Abramson SB, et al.: Controversies in COX-2 selective inhibition. J Rheumatol 2002, 29:1501\u20131510.", "journal-title": "J Rheumatol"}, {"key": "229_CR31", "doi-asserted-by": "crossref", "first-page": "65S", "DOI": "10.1016/S0002-9343(99)00369-1", "volume": "107", "author": "D.C. Brater", "year": "1999", "unstructured": "Brater DC: Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition. Am J Med 1999, 107:65S\u201370S.", "journal-title": "Am J Med"}, {"key": "229_CR32", "doi-asserted-by": "crossref", "first-page": "1465", "DOI": "10.1001/archinte.160.10.1465", "volume": "160", "author": "A. Whelton", "year": "2000", "unstructured": "Whelton A, Schulman G, Wallemark C, et al.: Effects of celecoxib and naproxen on renal function in the elderly. Arch Intern Med 2000, 160:1465\u20131470.", "journal-title": "Arch Intern Med"}, {"key": "229_CR33", "doi-asserted-by": "crossref", "first-page": "959", "DOI": "10.1016/S0002-9149(02)02661-9", "volume": "90", "author": "A. Whelton", "year": "2002", "unstructured": "Whelton A, White WB, Bello AE, et al.: Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or = 65 years of age with systemic hypertension and osteoarthritis. Am J Cardiol 2002, 90:959\u2013963.", "journal-title": "Am J Cardiol"}, {"issue": "5B", "key": "229_CR34", "doi-asserted-by": "crossref", "first-page": "13S", "DOI": "10.1016/S0002-9343(99)00113-8", "volume": "106", "author": "A. Whelton", "year": "1999", "unstructured": "Whelton A: Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999, 106(5B):13S\u201324S.", "journal-title": "Am J Med"}, {"key": "229_CR35", "doi-asserted-by": "crossref", "first-page": "61", "DOI": "10.1172/JCI0214752", "volume": "110", "author": "Z. Qi", "year": "2002", "unstructured": "Qi Z, Hao CM, Langenbach RI, et al.: Opposite effects of cyclooxygenase-1 and-2 activity on the pressor response to angiotensin II. J Clin Invest 2002, 110:61\u201369.", "journal-title": "J Clin Invest"}, {"key": "229_CR36", "doi-asserted-by": "crossref", "first-page": "2308", "DOI": "10.1161/01.CIR.0000101683.30157.0B", "volume": "108", "author": "M. Hermann", "year": "2003", "unstructured": "Hermann M, Camici G, Fratton A, et al.: Differential effects of selecctive cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension. Circulation 2003, 108:2308\u20132311.", "journal-title": "Circulation"}, {"key": "229_CR37", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1161/01.HYP.0000153053.82032.bf", "volume": "45", "author": "M. Hermann", "year": "2005", "unstructured": "Hermann M, Shaw S, Kiss E, et al.: Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension. Hypertension 2005, 45:193\u2013197.", "journal-title": "Hypertension"}, {"key": "229_CR38", "doi-asserted-by": "crossref", "first-page": "282", "DOI": "10.1002/art.21540", "volume": "54", "author": "B. Hinz", "year": "2006", "unstructured": "Hinz B, Dormann H, Brune K: More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxib. Arthritis Rheum 2006, 54:282\u2013291.", "journal-title": "Arthritis Rheum"}, {"key": "229_CR39", "first-page": "P2", "volume": "11", "author": "L.K. Winner", "year": "2005", "unstructured": "Winner LK, Elliot DJ, Miners JO, Knights KM: In vitro glucoronidation of aldosterone by human liver and kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UCT) 287: inhibition by non-steroidal anti-inflammatory drugs (NSAIDs). Proc Aust Soc Clin Exp Pharmacol Toxicol 2005, 11: P2\u201302.", "journal-title": "Proc Aust Soc Clin Exp Pharmacol Toxicol"}, {"key": "229_CR40", "doi-asserted-by": "crossref", "first-page": "738", "DOI": "10.1111/j.1365-2125.2006.02678.x", "volume": "61", "author": "K.M. Knights", "year": "2006", "unstructured": "Knights KM, Mangoni AA, Minors JO: Non-selective nonsteroidal anti-inflammatory drugs and cardiovascular events: is aldosterone the silent partner in crime? Br J Clin Pharmacol 2006, 61:738\u2013740.", "journal-title": "Br J Clin Pharmacol"}, {"key": "229_CR41", "doi-asserted-by": "crossref", "first-page": "929", "DOI": "10.1161/01.HYP.0000014323.99765.16", "volume": "39", "author": "W.B. White", "year": "2002", "unstructured": "White WB, Kent J, Taylor A, et al.: Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors. Hypertension 2002, 39:929\u2013934.", "journal-title": "Hypertension"}, {"key": "229_CR42", "doi-asserted-by": "crossref", "first-page": "574", "DOI": "10.1161/01.HYP.0000115921.55353.e0", "volume": "43", "author": "M. Izhar", "year": "2004", "unstructured": "Izhar M, Alausa T, Folker A, et al.: Effects of COX-inhibition on blood pressure and kidney function in ACE inhibitor-treated blacks and hispanics. Hypertension 2004, 43:574\u2013577.", "journal-title": "Hypertension"}, {"key": "229_CR43", "doi-asserted-by": "crossref", "first-page": "1049", "DOI": "10.1001/archinte.1995.00430100075009", "volume": "155", "author": "M.C. Houston", "year": "1995", "unstructured": "Houston MC, Weir M, Gray J, et al.: The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil. Arch Intern Med 1995, 155:1049\u20131054.", "journal-title": "Arch Intern Med"}, {"key": "229_CR44", "doi-asserted-by": "crossref", "first-page": "1751", "DOI": "10.1016/S0140-6736(04)16299-5", "volume": "363", "author": "M. Mamdani", "year": "2004", "unstructured": "Mamdani M, Juurlink DN, Lee DS, et al.: Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study. Lancet 2004, 363:1751\u20131756.", "journal-title": "Lancet"}, {"key": "229_CR45", "doi-asserted-by": "crossref", "first-page": "425", "DOI": "10.1016/S0002-9149(01)02265-2", "volume": "89", "author": "W.B. White", "year": "2002", "unstructured": "White WB, Faich G, Whelton A, et al.: Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac. Am J Cardiol 2002, 89:425\u2013430.", "journal-title": "Am J Cardiol"}, {"key": "229_CR46", "doi-asserted-by": "crossref", "first-page": "411", "DOI": "10.1016/S0002-9149(03)00659-3", "volume": "92", "author": "W.B. White", "year": "2003", "unstructured": "White WB, Faich G, Borer JS, Makuch RW: CV thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib. Am J Cardiol 2003, 92:411\u2013418.", "journal-title": "Am J Cardiol"}, {"key": "229_CR47", "unstructured": "White WB, West CR, Borer JS, et al.: Risk of CV events in patients receiving celecoxib. A metanalysis of randomized clinical trials. Am J Cardiol 2006, in press."}, {"key": "229_CR48", "unstructured": "Collaborative overview of randomized trials of antiplatelet therapy: I: prevention of death, myocardial infarction, and stroke. Antiplatelet Trialists\u2019 Collaboration. BMJ 1994, 308:81\u2013106.", "DOI": "10.1136/bmj.308.6921.81", "doi-asserted-by": "crossref"}, {"key": "229_CR49", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1016/S0140-6736(04)16894-3", "volume": "364", "author": "M.E. Farkouh", "year": "2004", "unstructured": "Farkouh ME, Kirshner H, Harrington RA, et al.: Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. Lancet 2004, 364:675\u2013684.", "journal-title": "Lancet"}, {"key": "229_CR50", "doi-asserted-by": "crossref", "first-page": "475", "DOI": "10.1016/S0140-6736(05)17864-7", "volume": "365", "author": "D.J. Graham", "year": "2005", "unstructured": "Graham DJ, Campen D, Hui R, et al.: Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 2005, 365:475\u2013481.", "journal-title": "Lancet"}, {"key": "229_CR51", "doi-asserted-by": "crossref", "first-page": "2906", "DOI": "10.1161/CIRCULATIONAHA.106.616219", "volume": "113", "author": "G.H. Gislason", "year": "2006", "unstructured": "Gislason GH, Jacobsen S, Rasmussen JN, et al.: Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective non-steroidal antiinflammatory drugs after acute infarction. Circulation 2006, 113:2906\u20132913.", "journal-title": "Circulation"}, {"key": "229_CR52", "doi-asserted-by": "crossref", "first-page": "1633", "DOI": "10.1001/jama.296.13.jrv60011", "volume": "296", "author": "P. McGettigan", "year": "2006", "unstructured": "McGettigan P, Henry D: Cardiovascular risk and inhibition of cyclooxygenases: A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase-2. JAMA 2006, 296:1633\u20131644.", "journal-title": "JAMA"}, {"key": "229_CR53", "doi-asserted-by": "crossref", "first-page": "1578", "DOI": "10.1161/CIRCULATIONAHA.105.595793", "volume": "113", "author": "A.T. Chan", "year": "2006", "unstructured": "Chan AT, Manson JE, Albert CM, et al.: Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation 2006, 113:1578\u20131587.", "journal-title": "Circulation"}, {"key": "229_CR54", "doi-asserted-by": "crossref", "first-page": "1071", "DOI": "10.1056/NEJMoa050405", "volume": "352", "author": "S.D. Solomon", "year": "2005", "unstructured": "Solomon SD, McMurray JJ, Pfeffer MA, et al.: Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005, 352:1071\u20131080.", "journal-title": "N Engl J Med"}, {"key": "229_CR55", "doi-asserted-by": "crossref", "first-page": "873", "DOI": "10.1056/NEJMoa061355", "volume": "355", "author": "M.M. Bertagnolli", "year": "2006", "unstructured": "Bertagnolli MM, Eagle CJ, Zauber AG, et al.: Celecoxib for the prevention of colorectal adenomas. N Engl J Med 2006, 355:873\u2013884.", "journal-title": "N Engl J Med"}, {"key": "229_CR56", "doi-asserted-by": "crossref", "first-page": "885", "DOI": "10.1056/NEJMoa061652", "volume": "355", "author": "N. Arber", "year": "2006", "unstructured": "Arber N, Eagle CJ, Spicak J, et al.: Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 2006, 355:885\u2013895.", "journal-title": "N Engl J Med"}, {"issue": "SupplIII", "key": "229_CR57", "first-page": "85", "volume": "64", "author": "G. Singh", "year": "2005", "unstructured": "Singh G, Mithal A, Triadafilopoulos G: Both selective COX-2 inhibitors and non-selective NSAIDs increase the risk of acute myocardial infarction in patients with arthritis: selectivity is with the patient not the drug class. Ann Rheum Dis 2005, 64(Suppl III):85.", "journal-title": "Ann Rheum Dis"}, {"key": "229_CR58", "first-page": "S57", "volume": "14", "author": "M.C. Sturkenboom", "year": "2005", "unstructured": "Sturkenboom MC, Dieleman J, Verhamme K, et al.: Cardiovascular events during use of COX-2 selective and non-selective NSAIDs. Pharmacoepidemiol Drug Saf 2005, 14:S57.", "journal-title": "Pharmacoepidemiol Drug Saf"}, {"key": "229_CR59", "doi-asserted-by": "crossref", "first-page": "1366", "DOI": "10.1136/bmj.330.7504.1366", "volume": "330", "author": "J. Hippisley-Cox", "year": "2005", "unstructured": "Hippisley-Cox J, Coupland C: Risk of myocardial infarction in patients taking cyclooxygenase inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 2005, 330:1366\u20131372.", "journal-title": "BMJ"}, {"key": "229_CR60", "doi-asserted-by": "crossref", "first-page": "979", "DOI": "10.1001/archinte.165.9.978", "volume": "165", "author": "S.P. Johnsen", "year": "2005", "unstructured": "Johnsen SP, Larsson H, Tarone RE, et al.: Risk of hospitalisation for myocardial infarction among users of rofecoxib, celecoxib and other NSAIDs: a population based case control study. Arch Intern Med 2005, 165:979\u2013984.", "journal-title": "Arch Intern Med"}, {"key": "229_CR61", "doi-asserted-by": "crossref", "first-page": "481", "DOI": "10.7326/0003-4819-142-7-200504050-00113", "volume": "142", "author": "L.E. Levesque", "year": "2005", "unstructured": "Levesque LE, Brophy JM, Zhang B: The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults. Ann Intern Med 2005, 142:481\u2013489.", "journal-title": "Ann Intern Med"}, {"key": "229_CR62", "doi-asserted-by": "crossref", "first-page": "985", "DOI": "10.1016/j.jacc.2003.08.064", "volume": "43", "author": "S.E. Kimmel", "year": "2004", "unstructured": "Kimmel SE, Berlin JA, Reilly M, et al.: The effects of non-selective non-aspirin non-steroidal anti-inflammatory medications on the risk of non-fatal myocardial infarction and their interaction with aspirin. J Am Coll Cardiol 2004, 43:985\u2013990.", "journal-title": "J Am Coll Cardiol"}, {"key": "229_CR63", "doi-asserted-by": "crossref", "first-page": "157", "DOI": "10.7326/0003-4819-142-3-200502010-00005", "volume": "142", "author": "S.E. Kimmel", "year": "2005", "unstructured": "Kimmel SE, Berlin JA, Reilly M, et al.: Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction. Ann Intern Med 2005, 142:157\u2013164.", "journal-title": "Ann Intern Med"}, {"key": "229_CR64", "doi-asserted-by": "crossref", "first-page": "1071", "DOI": "10.1016/S0140-6736(02)11131-7", "volume": "360", "author": "W.A. Ray", "year": "2002", "unstructured": "Ray WA, Stein CM, Daugherty JR, et al.: Cyclo-oxygenase-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet 2002, 360:1071\u20131073.", "journal-title": "Lancet"}, {"key": "229_CR65", "doi-asserted-by": "crossref", "first-page": "118", "DOI": "10.1016/S0140-6736(02)07370-1", "volume": "359", "author": "W.A. Ray", "year": "2002", "unstructured": "Ray WA, Stein CM, Hall K, et al.: Non-steroidal anti-inflammatory drugs and the risk of serious coronary heart disease: an observational cohort study. Lancet 2002, 359:118\u2013123.", "journal-title": "Lancet"}, {"key": "229_CR66", "doi-asserted-by": "crossref", "first-page": "2472", "DOI": "10.1001/archinte.164.22.2472", "volume": "164", "author": "L.M. Fischer", "year": "2004", "unstructured": "Fischer LM, Schlienger RG, Matter CM, et al.: Discontinuation of non-steroidal anti-inflammatory drug therapy and the risk of acute myocardial infarction. Arch Intern Med 2004, 164:2472\u20132476.", "journal-title": "Arch Intern Med"}, {"key": "229_CR67", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1186/1741-7015-3-17", "volume": "3", "author": "L.A. Garcia Rodriguez", "year": "2005", "unstructured": "Garcia Rodriguez LA, Gonzalez-Perez A: Long-term use of traditional of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population. BMC Med 2005, 3:17.", "journal-title": "BMC Med"}, {"key": "229_CR68", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1161/01.STR.0000053029.45352.A0", "volume": "34", "author": "S. Bak", "year": "2003", "unstructured": "Bak S, Andersen M, Tsiropoulos I, et al.: Risk of stroke associated with non-steroidal anti-inflammatory drugs. Stroke 2003, 34:379\u2013386.", "journal-title": "Stroke"}, {"key": "229_CR69", "doi-asserted-by": "crossref", "first-page": "1099", "DOI": "10.1001/archinte.162.10.1099", "volume": "162", "author": "D.H. Solomon", "year": "2002", "unstructured": "Solomon DH, Glynn RJ, Levin R, Avorn J: Non-steroidal anti-inflammatory drug use and acute myocardial infarction. Arch Intern Med 2002, 162:1099\u20131104.", "journal-title": "Arch Intern Med"}, {"key": "229_CR70", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1046/j.1365-2125.2002.01637.x", "volume": "54", "author": "R.G. Schlienger", "year": "2002", "unstructured": "Schlienger RG, Jick H, Meier CR: Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction. Br J Clin Pharmacol 2002, 54:327\u2013332.", "journal-title": "Br J Clin Pharmacol"}, {"key": "229_CR71", "doi-asserted-by": "crossref", "first-page": "1105", "DOI": "10.1001/archinte.162.10.1105", "volume": "162", "author": "D.J. Watson", "year": "2002", "unstructured": "Watson DJ, Rhodes T, Cai B, Guess HA: Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis. Arch Intern Med 2002, 162:1105\u20131110.", "journal-title": "Arch Intern Med"}, {"key": "229_CR72", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1016/S0140-6736(03)12509-3", "volume": "361", "author": "T.M. MacDonald", "year": "2003", "unstructured": "MacDonald TM, Wei L: Effect of ibuprofen on cardioprotective effect of aspirin. Lancet 2003, 361:573\u2013574.", "journal-title": "Lancet"}], "container-title": ["Current Pain and Headache Reports"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s11916-007-0229-x.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s11916-007-0229-x/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s11916-007-0229-x", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 2]], "date-time": "2019-06-02T00:38:20Z", "timestamp": 1559435900000}, "score": 20.272104, "issued": {"date-parts": [[2007, 12]]}, "references-count": 72, "journal-issue": {"published-print": {"date-parts": [[2007, 12]]}, "issue": "6"}, "alternative-id": ["229"], "URL": "http://dx.doi.org/10.1007/s11916-007-0229-x", "relation": {"cites": []}, "ISSN": ["1531-3433", "1534-3081"], "issn-type": [{"value": "1531-3433", "type": "print"}, {"value": "1534-3081", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T16:01:04Z", "timestamp": 1574438464402}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Hypertension"], "published-print": {"date-parts": [[2010, 6]]}, "DOI": "10.1097/01.hjh.0000379014.10568.aa", "type": "journal-article", "created": {"date-parts": [[2010, 6, 21]], "date-time": "2010-06-21T05:38:00Z", "timestamp": 1277098680000}, "page": "e276", "source": "Crossref", "is-referenced-by-count": 2, "title": ["NEW ANGIOTENSIN II RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL: COMPARISON TO VALSARTAN: PP.16.88"], "prefix": "10.1097", "volume": "28", "author": [{"given": "D", "family": "Sica", "sequence": "first", "affiliation": []}, {"given": "WB", "family": "White", "sequence": "additional", "affiliation": []}, {"given": "MA", "family": "Weber", "sequence": "additional", "affiliation": []}, {"given": "GL", "family": "Bakris", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Perez", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Cao", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Kupfer", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Journal of Hypertension"], "language": "en", "link": [{"URL": "http://journals.lww.com/jhypertension/Fulltext/10.1097/01.hjh.0000379014.10568.aa", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 29]], "date-time": "2018-11-29T13:57:22Z", "timestamp": 1543499842000}, "score": 20.172789, "subtitle": [""], "issued": {"date-parts": [[2010, 6]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1097/01.hjh.0000379014.10568.aa", "ISSN": ["0263-6352"], "issn-type": [{"value": "0263-6352", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T20:19:10Z", "timestamp": 1575231550073}, "reference-count": 0, "publisher": "OMICS Publishing Group", "issue": "06", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Mol Biomark Diagn"], "DOI": "10.4172/2155-9929.1000358", "type": "journal-article", "created": {"date-parts": [[2018, 1, 22]], "date-time": "2018-01-22T09:26:58Z", "timestamp": 1516613218000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["It Is Time to Consider Non-Pharmacologic Alternatives to Opioid Analgesics for Treating Chronic Pain"], "prefix": "10.4172", "volume": "08", "author": [{"given": "Paul F", "family": "White", "sequence": "first", "affiliation": []}], "member": "2674", "published-online": {"date-parts": [[2017]]}, "container-title": ["Journal of Molecular Biomarkers & Diagnosis"], "deposited": {"date-parts": [[2018, 1, 22]], "date-time": "2018-01-22T09:27:00Z", "timestamp": 1516613220000}, "score": 19.810574, "issued": {"date-parts": [[2017]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2017]]}, "issue": "06"}, "URL": "http://dx.doi.org/10.4172/2155-9929.1000358", "ISSN": ["2155-9929"], "issn-type": [{"value": "2155-9929", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:41:22Z", "timestamp": 1574113282989}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1997, 3, 1]], "date-time": "1997-03-01T00:00:00Z", "timestamp": 857174400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Hum Hypertens"], "published-print": {"date-parts": [[1997, 3]]}, "DOI": "10.1038/sj.jhh.1000416", "type": "journal-article", "created": {"date-parts": [[2002, 9, 4]], "date-time": "2002-09-04T17:29:54Z", "timestamp": 1031160594000}, "page": "163-169", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Evaluation of the Critikon 8100 and Spacelabs 90207 non-invasive blood pressure monitors using a test simulator"], "prefix": "10.1038", "volume": "11", "author": [{"given": "JN", "family": "Amoore", "sequence": "first", "affiliation": []}, {"given": "WB", "family": "Geake", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[1997, 12, 18]]}, "container-title": ["Journal of Human Hypertension"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/1000416.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1000416", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1000416.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 15]], "date-time": "2019-03-15T20:47:22Z", "timestamp": 1552682842000}, "score": 19.669853, "issued": {"date-parts": [[1997, 3]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1997, 3]]}, "issue": "3"}, "alternative-id": ["BF1000416"], "URL": "http://dx.doi.org/10.1038/sj.jhh.1000416", "ISSN": ["0950-9240", "1476-5527"], "issn-type": [{"value": "0950-9240", "type": "print"}, {"value": "1476-5527", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T13:51:46Z", "timestamp": 1574171506543}, "reference-count": 77, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Current Opinion in Nephrology and Hypertension"], "published-print": {"date-parts": [[2003, 9]]}, "DOI": "10.1097/00041552-200309000-00001", "type": "journal-article", "created": {"date-parts": [[2003, 8, 21]], "date-time": "2003-08-21T21:37:00Z", "timestamp": 1061501820000}, "page": "483-490", "source": "Crossref", "is-referenced-by-count": 21, "title": ["Diuretic use in stage 5 chronic kidney disease and end-stage renal disease"], "prefix": "10.1097", "volume": "12", "author": [{"given": "Domenic A", "family": "Sica", "sequence": "first", "affiliation": []}, {"given": "Todd WB", "family": "Gehr", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Current Opinion in Nephrology and Hypertension"], "language": "en", "deposited": {"date-parts": [[2018, 3, 5]], "date-time": "2018-03-05T07:18:55Z", "timestamp": 1520234335000}, "score": 19.621763, "subtitle": [""], "issued": {"date-parts": [[2003, 9]]}, "references-count": 77, "journal-issue": {"issue": "5"}, "URL": "http://dx.doi.org/10.1097/00041552-200309000-00001", "ISSN": ["1062-4821"], "issn-type": [{"value": "1062-4821", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T08:55:56Z", "timestamp": 1575104156640}, "reference-count": 28, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Nurse Specialist"], "published-print": {"date-parts": [[1999, 7]]}, "DOI": "10.1097/00002800-199907000-00005", "type": "journal-article", "created": {"date-parts": [[2003, 11, 11]], "date-time": "2003-11-11T10:59:48Z", "timestamp": 1068548388000}, "page": "166-172", "source": "Crossref", "is-referenced-by-count": 25, "title": ["Changing Pain Management Practice and Impacting on Patient Outcomes"], "prefix": "10.1097", "volume": "13", "author": [{"given": "Carole L.", "family": "White", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["Clinical Nurse Specialist"], "language": "en", "deposited": {"date-parts": [[2017, 6, 16]], "date-time": "2017-06-16T02:06:55Z", "timestamp": 1497578815000}, "score": 19.4994, "subtitle": [""], "issued": {"date-parts": [[1999, 7]]}, "references-count": 28, "journal-issue": {"issue": "4"}, "URL": "http://dx.doi.org/10.1097/00002800-199907000-00005", "ISSN": ["0887-6274"], "issn-type": [{"value": "0887-6274", "type": "print"}], "subject": ["Assessment and Diagnosis", "LPN and LVN", "Advanced and Specialised Nursing", "Leadership and Management"]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}